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CHAPTER I 
INTRODUCTION 
The regulation of circulating blood glucose levels by hepatic 
mechanisms is critical for life. Adequate glucose production by the 
liver depends on proper circulatory hemodynamics as wel 1 as 
neuroendocrine regulation. The main processes of glucose delivery into 
the blood are glycogenolysis in the fed state and gluconeogenesis in the 
fasted state. The rates of hepatic glycogenolysis and gluconeogenesis 
are determined by many factors--hormones, hepatic blood flow, oxygen 
supply to the liver and intracellular levels of substrate as well as 
adenine nucleotides. The major function of intracellular ATP is as a 
free energy supply for most active processes including muscle 
contraction, active transport of substances through the biological 
membranes, and biosynthesis of cellular components. 
In addition, extracellular ATP and related adenylate affect both 
vascular resistance and tissue metabolism. Adenosine and adenine 
nucleotides are potent vasodilators in vascular beds incluaing the 
skeletal muscle, skin, intestinal vessels and the coronary 
circulation. On the other hand, a vasoconstrictor response to adenine 
compounds has been reported in various tissue preparations, viz, ATP 
increased the tension of canine saphenous vein strips, aortic strips and 
human umbilical arterial strips. ATP also contracted the isolated 
perfused renal artery. Therefore, the vascular response to ATP depends 
1 
2 
on the tissue preparation under study. However, the exact mechanisms 
for ATP-induced changes in vascular resistance are obscure. 
Exogenous ATP produces hyperglycemia in vivo and in the perfused 
liver. In histochemical and electrophysiological studies, purine 
nucleotides, especially ATP were proposed as a neurotransmitter in 
various mammalian organs. A purinoreceptor-mediated glucose output for 
the ATP-induced hyperglycemia has been proposed by Clemens et al. (84) 
but the mechanism of hepatic glucose output is unknown. 
Prostaglandins are recognized to play regulatory roles in smooth 
muscle tone and cell metabolism. There are many kinds of prostaglandins 
and the responses to prostaglandins depend on the animal species, the 
tissues, and prostaglandin type. ca++ ion mobilization may be involved 
in prostaglandin action on smooth m~cle. Cellular metabolism is also 
affected by prostaglandins due to changes in adenylate cyclase 
activity. Al tough some controversy exists, many investigators have 
demonstrated that prostaglandin E stimulates adenylate cyclase in the 
hepatocyte. Many stimulants release prostaglandins--such as drugs, 
neural, and hormonal stimulation. ATP is also a potent stimulator of 
prostaglandin release from a number of tissues including liver, heart, 
lung, spleen and fat pad. Therefore, ATP-induced changes in vascular 
resistance and hepatic glucose production may involve a role for 
prostaglandins. If prostaglandins are involved in the ATP-induced 
changes in vascular resistance and hepatic glucose output, then 
indomethacin, a prostaglandin synthesis inhibitor, should attenuate ATP 
actions. 
3 
The overall purposes of present research were 1) to analyze the 
effects of exogenous ATP on the hepatic circulation in the perfused 
liver using measurements of both portal vein and hepatic arterial 
resistances and hepatic capacitance, 2) to characterize ATP action on 
liver carbohydrate metabolism including glucose and lactate production 
in the perfused liver or isolated hepatocyte preparation as well as 
oxygen consumption and K+ movements in the perfused liver, and 3) to 
elucidate the mechanism of ATP on hepatic hemodynamics and liver 
metabolism using indomethacin treatment. 
CHAPTER II 
REVIEW OF RELATED LITERATURE 
A. Experimental Models for the Study of Liver Metabolism and 
Hemodynamics 
1. VARIOUS TECHNIQUES FOR THE STUDY OF LIVER METABOLISM 
Various experimental models have been used for the study of liver 
metabolism--such as in vivo studies, perfused liver preparations, liver 
slice techniques, isolated hepatocyte preparations, liver homogenates, 
and isolated subcellular preparation. Al though an in vivo study is 
physiologically the most ideal, the host of interactions with other 
organs complicates interpretation of specific liver functions. The 
liver slice technique is appropriate for qualitative elucidation of 
constituent functions and metabolic pathways; however, liver slices--
although they consist mainly of intact cells--have proved unsuitable for 
certain studies because essential components of liver metabolism are 
greatly changed by slicing. According to Krebs et al. (222), liver 
slices lose most of their nucleotides during incubation--for example, in 
the case of ATP, more than 70% is lost in 10 minutes of slice 
incubation. The rates of gluconeogenesis and ketone body formation are 
also much lower in liver slices than in the perfused liver and were 
accounted for by loss of ATP from the liver slices during incubation 
(221, 292). 
4 
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The perfused liver preparation has been widely employed in 
quantitative studies of liver metabolism. The first liver perfusion was 
conducted by Claude Bernard (27) in 1855 in the course of his classical 
observations on glycogen breakdown in the dog. After his initial study 
many investigators perfused the liver in different species and with a 
variety of techniques. In early investigations mainly large mammalian 
livers were used for perfusion. Trowell (333) first perfused the rat 
liver for a study of urea synthesis from annnonia. In his study the 
liver was perfused in a retrograde direction, namely, oxygenated saline 
was pumped into the vena cava and exited from the portal vein. He also 
reported that the liver perfusion preparation excelled in function over 
liver slices. Subsequently Miller et al. ( 248) developed a perfusion-
aeration apparatus and an operative procedure for the perfusion of the 
rat liver with oxygenated blood. Miller et al. (248) then employed 
their model to establish the dominant role of the liver in the 
biosynthesis of the plasma proteins. The apparatus and operative 
technique developed by Miller have been extensively used by many 
investigators for study of liver processes, including carbohydrate, 
protein and lipid metabolism, hormone action, membrane transport and ion 
fluxes. 
Since the liver consists of 60% hepatic parenchymal cells by 
number and the parenchymal cells actually contribute over 87% to the 
total liver volume ( 155), isolated liver cell preparations are widely 
used to study liver metabolic functions. In the early development of 
methods for the isolation of parenchymal cells, physical methods for 
6 
instance, mechanical dispersion were employed (4, 39, 196, 204). 
However, the physical methods have not been widely accepted because of 
defects of cell damage and low metabolic rate (29, 31). Consequently 
Howard et al. ( 184) isolated he pa tocytes with an enzymatic technique 
which incubated liver slices with collagenase and hyaluronidase. They 
obtained structually and functionally intact hepatocytes. A 
disadvantage of this technique was the low yield of only about 5% of the 
original tissue. Berry and Friend (30) introduced the enzymatic 
technique using liver perfusion rather than incubat~on of slices. They 
used calcium-free Hanks' solution containing 0.05% collagenase and 0.1% 
hyaluronidase and obtained more than a 50% yield of intact hepatocytes. 
According to Krebs et al. (222), the perfused liver and isolated 
hepatocyte preparations have almost the same performance in oxygen 
consumption, glucose production, _urea synthesis and ketone body 
formation. Isolated hepatocytes also retain adenine nucleotides (176, 
222) and K+ ions (18) and exhibit appropriate responses to hormones 
(201). Therefore, the isolated hepatocyte preparation is one of the 
favored models for the study of liver metabolism. 
2. PERFUSION MEDIUM AND PERFUSION FLOW FOR ISOLATED LIVER MODELS 
In general, there are two kinds of liver perfusion medium--
erythrocyte containing medium and erythrocyte free-medium. Erythrocyte 
containing mediwn has the advantage that due to a high oxygen carrying 
capacity, it allows much lower flow rate to achieve adequate oxygenation 
and thus avoids hypoxic injury. Usually the perfusion flow rates in 
models using rat whole blood or with red blood cell containing medium 
7 
are lower than those in models using red blood cell free medium (1 B, 
119, 140, 197, 214, 248, 295, 310). However, in some experiments the 
value of red blood cell containing medium is limited because 1) red 
blood cells consume glucose and produce lactate (151), 2) red blood 
cells are hemolyzed during perfusion and release K+ ions (10, 307), 1) 
it is difficult to elucidate porphyrin metabolism by the liver perfused 
with red blood cells (298) and 4) in models using a non-recirculating 
system (once-through perfusion), large volumes of perfusion medium are 
required. These considerations favor the use of red blood cell free 
medium in various experimental protocols. 
If red blood cell free-medium is used, the flow rate must be 
incresed several times greater than the physiologic portal vein flow in 
order to insure sufficient oxygen supply to the liver. An inappropriate 
low perfusion may produce cell injury. According to Schmucker and 
Curtis (297), a low perfusion flow rate of 15 ml/min (approx. 1.3 
ml/gm/min) with KRB resulted in extensive hepatocyte injury suggestive 
of hypoxia. In contrast, high perfusion flow of 72 ml/min (approx. 6.1 
ml/gm/min) caused sinusoid distension and severe endothelial cell 
injury. Thus it is important to maintain an adequate perfusion flow to 
prevent both hypoxia and endothelial cell injury. Some investigators 
maintained low liver temperature to reduce oxygen demand (159, 323). In 
addition, Schmucker et al. (298) reported that hyperbaric oxygenation 
protected the liver from hypoxia and endothelial cell injury at near 
physiologic hepatic portal vein flow rates. 
Several groups have reported the use of certain inert 
8 
fluorocarbons which have high solubility characteristics for oxygen and 
carbon dioxide in perfusion systems. According to Triner et al. (311), 
the liver perfused with fluorocarbon FC-47 emulsion with bicarbonate 
buffer had higher oxygen extraction and greater gluconeogenesis. 
Goodman et al. (151) compared three different perfusion media i.e. 
erythrocyte-free KRB buffer, erythrocyte-KRB buffer (at 15% hematocrit) 
and fluorocarbon (FC-47)-KRB buffer emulsion, with respect to their 
ability to maintain a viable perfused rat liver preparation. At flow 
rates of 30 ml/min gluconeogenesis, oxygen consumption, lactate and 
ketone body production and hepatic ATP concentration were the same with 
all three buffer preparations. However, at a relatively low perfusion 
flow ( 20 ml/min or less) the fluorocarbon-KRB and the erythrocyte-KRB 
buffer maintained better function than the erythrocyte free buffer due 
to their greater oxygen delivery. They concluded that fluorocarbon-KRB 
buffer had actually identical ability in their metabolic behavior to 
livers perfused with erythrocyte-containing buffer. Thus, fluorocarbon-
KRB has certain advantages: it permits lower perfusion flow rates than 
erythrocyte-free medium with identical functions and it prevents 
inherent problems in using red blood cells such as consuming glucose and 
producing lactate etc. However, further studies of metabolic and 
histological alteration have to be accomplished to exclude any 
deleterious effect of fluorocarbon emulsions such as hepatotoxicity and 
uptake of these particles by liver cells (81). 
3. ANALYSIS OF HEPATIC HEMODYNAMICS 
The hepatic circulation has a unique vascular arrangement of dual 
9 
blood supplies consisting of the portal vein and hepatic artery. The 
portal vein collects blood from pancreas, stomach, spleen, small 
intestine and large intestine; thus it carries absorbed nutrients, 
hormones and toxins to hepatic parenchymal, and reticuloendothelial 
cells. The hepatic artery which arises from the celiac artery carries 
oxygen-enriched blood to the liver. The portal vein provides the liver 
with 67-80% of its blood supply, while the hepatic artery contributes 
the remaining 20-33% of hepatic blood flow (156). Hepatic blood flow 
varies with animal species; it ranges from 104 in human, 110 in dog, 134 
in cat and 150 ml/min/lOOgm liver in rat (156, 158). 
In the hepatic lobes the large portal vein branches repeatedly 
into small vessels and finally are connected with the sinusoids. The 
hepatic artery also branches and eventually the hepatic arterioles also 
join the sinusoids. After circulation through the sinusoids, the blood 
paths merge into the central vein and finally reach the inferior vena 
cava tributaries. 
The he pa tic sinusoids are specialized capillaries. They are on 
average 330 um long and 9-12 um wide--but this width can enlarge to 30 
um when the sinusoidal pressure increases (72). The wall of sinusoids 
consist of a discontinuous basement membrane, endothelial cells, and 
Kupffer cells. It has varying sized fenestrations of 100-200 nm in 
diameter. Because of these fenestrations, sinusoids have high 
permeability to substances, even to relatively high molecular weights of 
250,000 (65). Sinusoidal porosity allows perfusion of the space of 
Disse easily possible even with low intersinusoidal pressure (2-3 mmHg). 
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Portal vein pressure ranges from 5-10 mmHg, while mean hepatic 
arterial pressure is about 100 mmHg (156, 158). This indicates that the 
portal vein circulation has a low pressure-low resistance character, 
while the hepatic artery has a high-pressure-high resistance nature. 
Therefore, small changes of portal vein pressure cause large changes in 
flow. There are several sites which produce vascular resistance in the 
liver. The wall of portal venules and hepatic venules as well as the 
hepatic arterioles contain smooth muscle that modifies vascular 
resistance and also controls the liver capacitance. McCuskey (241) 
reported the presence of sphincters consisting of contractile 
endothelial cells located at the junctions of sinusoids with portal 
venules (inlet spincters), with central venules (outlet sphincters) and 
intersinusoidal sinusoids (sphincters of intersinusoids). These 
spincter systems also contribute- to changes in hepatic vascular 
resistance. 
Hepatic vascular resistance is regulated by various stimuli 
including hormones, drugs and nerve stimulation. Hepatic nerves, 
particularly sympathetic nerves, exert major effects on the hepatic 
circulation. In contrast, parasympathetic nerves only sparsely innervate 
the hepatic vascular beds. 
the resistance of portal 
Stimulation of sympathetic nerves increases 
vein, hepatic vein and hepatic artery, 
consequently it causes net decreases in hepatic capacitance. Since the 
liver contains a large volume of stored blood, changes in liver 
capacitance may contribute to redistribution of blood into the pulmonary 
and systemic circulations. 
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There are reciprocal relationships between hepatic portal venous 
flow and hepatic arterial flow. When a branch of the portal vein was 
occluded, hepatic arterial flow to that area increased and when portal 
venous blood flow increased, hepatic arterial flow decreased (157, 
165). This response may serve to maintain total hepatic blood flow and 
sinusoidal perfusion pressure. However, the mechanism of this 
reciprocal relationship of flow has not yet been elucidated. 
B. Characteristics of Adenine Nucleotides 
1. BIOCHEMICAL CHARACTERISTICS OF ATP 
Adenosine triphosphate (ATP) was first discovered in mammalian 
muscle extracts by Fiske and Subbarow (128). A chemical structure was 
established by Lythgoe and Todd (234). ATP was synthesized by Baddiley 
et al (14). ATP consists of an adenine, a ribose, and a triphosphate 
unit. At a pH of 7.0 ATP is a highly charged anion and sodium salts are 
stable in aqueous solution for months at -15°c but for only 1 week at 
4°C (22). In solution ATP slowly decays forming 5'-adenylic acid 
(AMP). ATP is an energy-rich molecule because it contains two 
phosphoanhydride bonds (P-0-P). 7.3 Kcal/mole of free energy is 
liberated when ATP is hydrolyzed to ADP and orthophosphate (Pi) or 
hydrolyzed to AMP and pyrophosphate (PPi) (226). Biological systems use 
the free energy from ATP hydrolysis for such active processes as muscle 
contraction, biosynthesis of carbohydrates, proteins, nucleic acids and 
lipids and active uptake of many substances through the biological 
membrane. 
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ADP and AMP as well as ATP also play important roles in 
intracellular functions including glycogenolysis, glycolysis and 
mitochondrial respiration. Furthermore, the balance of these adenine 
nucleotides in the cytosol has often a more important influence than the 
actual concentration of each nucleotide because of their opposite 
allosteric activatory or inhibitory activity. ATP, ADP and AMP are 
interconvertible and usually the sum of their concentrations in the 
living cells remains relatively constant. Atkinson (12) established the 
concept of energy charge ([ATP] + 1/2[ADP]/[ATP] + [ADP] + [AMP]) which 
reflects the cellular energy balance between the energy generating 
processes and energy utilizing processes. According to Ozawa (269), the 
energy charge of the liver cells decreases under various cell conditions 
such as in endotoxicosis, in hypoxia and in hemorrhagic shock. In these 
states hepatic intracellular ATP _levels decrease and AMP levels 
increase. 
2. MOVEMENTS OF ATP ACROSS THE PLASMA MEMBRANE 
It is controversial if ATP crosses cell plasma membranes. Glynn 
(150) reported that ATP is impermeable to the plasma membrane; however, 
many investigators have reported that ATP does indeed cross the plasma 
membrane. Buchthal et al. (43) observed that ATP caused twitch-like or 
short tetanus-like contraction and caused birefringence of isolated frog 
skeletal muscle. In this study they suggested that ATP permeates the 
membrane of the muscle fiber. Chaudry and his associates have provided 
strong evidence of ATP movements across the plasma membrane in various 
tissues by using radioisotope labelled adenine compounds. Chaudry and 
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Gould (76) reported that soleus muscle takes up ATP from the external 
medium. In their study 14c-labelled ATP and ADP were found in the 
muscle and the data ruled out the possibility that ATP arose by 
synthesis from taken up adenosine. Chaudry et al. (80) have also 
demonstrated the uptake of ATP by liver and kidney slices, and they 
confirmed that this intracellular ATP was due to the movement of ATP 
itself from medium and not due to the resynthesis of ATP from its 
breakdown products. In further studies they have shown ATP uptake by 
rat soleus muscle using dual labelled ATP ( 32P-ATP and 14c-ATP). They 
also proposed that the transport of ATP into the cell would be a 
carrier-mediated process (74). 
Similar results were obtained in the perfused rat kidney (319) 
and kidney cortex slice preparations (239). ATP added in the medium 
increased ATP content in the kidney tissues. Sharma and Eiseman (305) 
demonstrated ATP uptake by heart tissue; ATP treated rats following 
hemorrhagic shock have high content of ATP in their cardiac tissue. 
Pant et al. (270) have demonstrated that ATP movements across the squid 
axonal membrane and reported ATP ( y-32P-ATP) in the extracellular space 
is utilized in the process of intracellular phosphorylation after 
transport into the axoplasm. ATP movements across the plasma membrane 
have been reported in the lymphoma cell (13). When ATP was added to the 
incubation medium of intact mouse lymphoma cells, the cyclic AMP level 
was enhanced with adenosine transport inhibitor. They interpreted that 
ATP enters the cell and serves as substrate for adenylate cyclase. 
On the other hand, release of ATP into the plasma from various 
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cells has also been reported. Forrester and Lind ( 137) reported that 
arterial and venous blood of a human subject had 0 .19 ug/ml and 0. 7 
ug/ml of ATP respectively. Forrester (136) measured the rate of 
appearance of ATP in the blood during exercise as approximately 7.5-10.5 
ug/min. He suggested that ATP detected in the venous effluent is 
derived from active skeletal muscle. The release of ATP from isolated 
heart cells has also been demonstrated (139). It was found that 0.34 + 
0.22 uM of ATP/mg protein was released by heart cells maintained in the 
oxygenated condition, while 1.28 + 0.41 uM of ATP/mg protein was 
released by cells under hypoxic conditions. Other tissues may also be 
sources of ATP in the plasma, including red blood cells (20, 133), 
vascular endothelial and smooth muscle cells ( 276), and nervous cells 
(183). In particular, the release of ATP from purinergic nerves as a 
neurotransmitter has been well recognized (52, 55, 58, 59, 321). Thus, 
on the basis of the above described studies, the release and subsequent 
uptake of extracellular ATP by the various cells may be normal 
physiological processes which are perturbed in various pathophysiologic 
states. 
C. Physiological Role .£!.Extracellular ATP 
1. ATP AND VASCULAR RESISTANCE 
Adenosine and adenine nucleotides (AMP, ADP and ATP) are potent 
vasodilators in most vascular beds. In 1929 Drury and Szent-Gyorgyi 
(107) first reported that dog carotid arterial pressure decreased 
following injection of adenosine and AMP. This vasodilator activity has 
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subsequently been demonstrated in various vascular beds, including 
coronary (23, 28, 97, 108, 132, 349), skeletal muscle (132, 216) human 
hand and forearm (110), forelimb (141), hindlimb (326), skin (132), ear 
(23) and intestinal vessels (90, 132, 161). Many investigators have 
attempted to correlate adenosine and adenine nucleotides to local 
regulation of blood flow but the hypothesis is accepted mainly in the 
coronary circulation (28; 162). 
The relative vasodilator potency of the different adenosine 
compounds has been reported. Windbury et al. ( 348) determined the 
relative coronary dilator activity in molar potency values as follows; 
ATP 100, ADP 95, AMP 28, adenosine 25 and adenine inactive. Similar 
results were reported by Fleisch and Weger (129); for the cat anrl dog, 
ATP was a hundred times stronger than AMP as a dilator of the peripheral 
vessels. In isolated canine femoral arteries, the relaxation response 
to adenine nucleotides were ordered as follows: ATP = ADP ) AMP = 
adenosine (246). However, according to Gillespie (148), adenine is most 
active in coronary vasodilation; the order of activity of the adenine 
compounds is adenosine ) AMP > ATP. Kalckar and Lowry (203) failed to 
find any potency differences between three adenine nucleotides on rabbit 
arterial pressure by injection of equimolar amounts of AMP, ADP and 
ATP. Thus, quantitative comparison of the dilator activity for 
adenosine, AMP, ADP, and ATP is not clearly defined. 
The magnesium salt of ATP (ATP-MgC1 2) as well as the sodium salt 
was used in some experiments, because there is some evidence that the 
ATP in the cell is present in ATP-Mg complex (32). Duff et al. (110) 
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compared vasodilator activity of magnesium salt with that of the sodium 
salt. While both substances were potent vasodilators, the dilator 
effect of the magnesium salt was greater than that of sodium salt. 
A vasoconstrictor response to adenine compounds has also been 
reported in various tissue preparations. According to Ismail and Hems 
(193), adenosine caused vasoconstriction in perfused rat liver. In the 
renal circulation adenosine, AMP, and ADP increased renal vascular 
resistance (166, 185, 268, 329). Hrdina et al. (185) demonstrated 
vasoconstrictor effects of ATP on isolated perfused rat renal 
arteries. The contractile effect 
concentration in the perfusion medium. 
of ATP was sensitive to ca++ 
With low Ca++ concentration in 
the medium, ATP had very little activity or was inactive. However, 
Scott et al. (300) reported that injection of adenosine into the renal 
artery increased renal vascular resistance, while injection of ATP 
decreased renal vascular resistance. Verhaeghe (338) demonstrated 
vasoconstrictor effects of adenosine nucleotides in the isolated vein. 
ATP and ADP but not adenosine increased basal tension of unstimulated 
(relaxed) dog saphenous vein strips. In contracted strips as induced by 
acetylcholine or norepinephrine, low concentrations ( 10-6 - 10-5M) of 
ATP or ADP caused relaxation, whereas high concentrations (10-4 - 10-3M) 
of both adenine nucleotides caused further contraction. Alpha-
adrenergic blockade with phentolamine did not alter the contraction 
induced by ATP and ADP but removal of Ca++ from the incubation medium 
prevented the contraction induced by both adenine nucleotides. Similar 
results were reported in the isolated aortic strips (143). ATP caused a 
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contraction of a relaxed strip, whereas it caused relaxation in 
contracted aortic strips. Burnstock et al. (60) reported variations in 
effects of ATP in animal species. ATP produced relaxation or some 
biphasic response of the rabbit portal vein whereas ATP caused only 
contraction in the guinea-pig portal vein. Therefore, the responses to 
ATP or adenine compounds depend on the tissue pre para ti on under study, 
the dose of agent employed, and the contractile state of the test 
preparation. 
2. ATP AS A NEUROTRANSMITTER 
Burnstock and his associates have pursued a purinergic 
neurotransmission hypothesis. Burns tock et al. ( 53, 54) observed a 
transitory relaxation and hyperpolarization during nerve stimulation in 
guinea-pig taenia coli smooth muscle_after blocking both adrenergic and 
cholinergic nerve transmission with guanethidine and atropine. They 
confirmed the presence of non-adrenergic, non-cholinergic nerves in 
various organ systems including the gastrointestinal tract, urinary 
bladder, esophagus, trachea, lung and cardiovascular system (48, 56, 58, 
59, 64, 144). In further studies, substances such as catecholamines, 5-
hydroxytryptamine, histamine, prostaglandins, several amino acids, some 
polypeptides, and purine compounds were tested to identify the 
transmitter in non-adrenergic, non-cholinergic nerves of various smooth 
muscle. By a systematic series of experiments, ATP, a purine 
nucleotide, was recognized as the possible neurotransmitter (55, 61). 
ATP was then shown to satisfy the criteria which are necessary for 
definition of a substance as a neurotransmitter: properties of 
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synthesis, storage, release, inactivation, ability to mimic response to 
nerve stimulation, and existence of receptor on the effective tissue. 
Regarding synthesis and storage, Su et al. (321) demonstrated 
uptake and resynthesis of purine derivatives by guinea-pig taenia-
coli. When the taenia coli preparations which included nerve terminals 
were incubated with [3HJ adenosine, tissue uptake of adenosine occurred, 
and approximately 60% of [3HJ-adenosine was converted into and retained 
as [3H] ATP. In an ultrastructural study of non-adrenergic and non-
cholinergic nerve endings, large opaque vesicles which are not affected 
by 6-hydroxydopamine (used as a marker to identify catecholamine-
containing vesicles) were identified (291). Histochemical study has 
also demonstrated an ATP-rich microsomal fraction in the non-adrenergic, 
non-cholinergic nerve endings (86). Burnstock (49) offered the term 
"purinergic nerve" for this non-adrenergic, non-cholinergic nerve which 
utilizes ATP as the principal neurotransmitter. 
Su et al. (321) demonstrated ATP release by nerve stimulation • 
[3HJ ATP resynthesized from [3H]-adenosine was released into the medium 
by stimulation of nerve containing both guanethidine and atropine. 
Burnstock et al. (59) further reported direct evidence for ATP release 
from purinergic nerves in the guinea-pig taenia coli and bladder. While 
a large amount of ATP was released by purinergic nerve stimulation from 
guinea-pig taenia coli, there was no significant increase of ATP release 
during direct muscle stimulation which developed similar responses. 
Exogenously applied ATP mimicked mechanical and 
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electrophysiological responses to purinergic nerve stimulation. 
According to Jager and Schevers (195), ATP produced hyperpolarization 
and relaxation in guinea-pig taenia caecum and purinergic nerve 
stimulation also caused hyperpolarization and smooth muscle 
relaxation. In addition, 13 - Y-methylene ATP (APPCP) which is resistant 
to degradation to AMP and adenosine are 100-fold more potent than ATP 
and caused phasic contractions which mimicked an atropine-resistant 
response to nerve stimulation (42). 
ATP action decays rapidly after application which indicates that 
tissues have an efficient ATP inactivation mechanism. Ectonucleotidases 
such as nucleoside triphosphatase, nucleoside diphosphatase, and 5'-
nucleosidase as well as Mg++-activated ATPase are found in various 
tissues including vascular endothelial cells, vascular smooth muscle 
cells, red blood cells and plasma (88, 138, 188, 272, 274, 275). The 
ectonucleotidase system degrades ATP to ADP, AMP, and finally to 
adenosine; the adenosine and some of adenine nucleotides are then 
uptaken by nerve or smooth muscle (321). 
Burnstock (50) have proposed two types of purinergic receptors--
P1 and P2--in the effective smooth muscle. P1 purinergic receptors are 
most sensitive to adenosine and are blocked by methylxanthines. P2 
purinergic receptors are most sensitive to ATP and are blocked by 
quinidine, 2-substituted imidazolines and apamin. The mechanisms by 
which ATP binding to the receptor produces smooth muscle activation is 
still not well-known. Burnstock (52) has suggested that ion movements 
and/or prostaglandin release by receptor activation may be possible 
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mechanisms of smooth muscle contraction or relaxation. 
3. ATP ACTION ON CELL METABOLISM AND ION MOVEMENT 
Exogenous ATP affects glucose metabolism. Levine (228) 
demonstrated hyperglycemic effects by administration of adenine 
nucleotides ~ vivo. Both ATP and 3' ,S'-cyclic AMP administration 
increased blood glucose levels and reduced rat liver glycogen 
contents. Similar effects have been observed by Filkins and Buchanan 
(126). ATP-MgC12 (10 umoles, iv) produced hyperglycemia in control rats 
and prevented endotoxin-induced hypoglycemia. Levine (228) failed to 
demonstrate hyperglycemia in perfused liver by ATP (lmM). In contrast, 
Clemens et al. (84) reported that ATP-MgC1 2 ()5 x 10-6M) stimulated 
glycogenolysis in the isolated perfused rat liver. Furthermore, at a 
low concentration of ATP-MgC1 2 ( 10--9M), gluconeogenesis was increased 
whereas at concentrations over 5 x 10-SM gluconeogenesis was decreased 
(84). In a further study Clemens et al. ( 83) observed increments of 
glycogenolysis and reductions of gluconeogenesis in isolated rat 
hepatocytes at an ATP-MgC1 2 concentration of 10-
4M. It was proposed 
that the stimulation of glycogenolysis is mediated by purinergic 
receptor on the hepatocyte and that inhibition of gluconeogenesis is 
mediated via adenosine. Inhibition of gluconeogenesis by ATP ( 2 .SmM) 
was also observed in the rat kidney-cortex slices and isolated perfused 
rat kidney (339). 
ATP reduced renal metabolism as evidenced by Maxild (239) who 
reported that externally added ATP inhibited oxygen consumption, p-
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amino-hippurate (PAH) accumulation and 14c-glucose degradation in the 
cortical slices of the rabbit kidney. He also found an elevation of ATP 
concentration in the cortical slices with exogenous ATP (0.1-lOmM). He 
interpreted that the reductions of glucose degradation and oxygen 
consumption are presumably due to allosteric inhibition of glycolysis 
and mitochondrial respiration via increased level of ATP in the 
tissue. In contrast, Weidemann et al. (33) reported that glucose uptake 
by kidney cortex slices was stimulated by added ATP; but oxygen 
consumption by kidney slices was not significantly affected by ATP. 
Thus effects of ATP on glucose degradation and oxygen consumption by the 
kidney are controversial. However, Clemens et al (84) reported that ATP 
(10-4M) decreased oxygen consumption in the isolated perfused rat liver. 
Various stimuli including hormones, drugs and nerve stimulation 
cause changes in cell membrane permeability. Exogenous ATP also 
increased cell membrane permeability to several ions such as Na+, K+ and 
Ca+t in various tissues. Rozengurt et al. (293) reported that 
externally added ATP (0.5 mM) produced 86Rb (an index of K+ movement) 
efflux in the cultured 3T6 mouse cell line. Similar effects on K+ 
efflux have been observed in isolated hepatocytes (46) and in 
erythroleukemia cells (69) where extracellular ATP stimulated K+ efflux 
and Na+ influx. Indirect evidence for increased K+ permeability (PK) by 
ATP comes from studies of changes in membrane potential. ATP produced 
hyperpolarization in guinea-pig liver slice (200) and the guinea-pig 
taenia caecum (195). Many investigators have suggested the possibility 
that the increase in PK by ATP is a consequence of a rise in the 
22 
++ intracellular Ca ion. ATP increased ca++ uptake in various cells 
including rat mast cells (91), isolated intestinal epithelial cells 
(213) and Ehrlich ascites-tumour cells (23). Dahlquist et al. (93) 
reported that exogenous ATP induced a prompt increase in Na+ influx and 
K+ efflux in the rat mast cells and this K+ efflux was prevented by 
blocking ca++ influx by the presence of Lac1 3• Burgess et al. (46) 
demonstrated that A23187, a divalent cationophore, increased K+ efflux 
in the isolated hepatocytes. In this study they also observed K+ efflux 
by addition of ATP into the medium. These reports suggest that ATP-
induced K+ efflux is Ca++-dependent process. 
4. THERAPEUTIC USES OF ATP 
In 1964 Talaat et al. (328) first introduced ATP therapy in 
experimental studies of shock and-- reported that infusion of ATP 
increased survival rates in hemorrhagic shock. Beneficial effects of 
ATP for the survival rates and recovery from organ failure have been 
proved in various shock models. ATP-MgC1 2 treatment increased survival 
rates after hemorrhagic shock (103, 217, 305), endotoxin shock (126, 
142), in burn (352), following hepatic ischemia (180, 181), and insulin 
induced seizure deaths (125). Treatment with ATP also increased 
survival time in a lethally hypoxic condition such that mice that 
received ATP (i.p.) had a significant longer survival time in 5% 02-95% 
N2 mixture (220). 
ATP enhanced recovery from acute renal failure. Siegel et al. 
(309) reported that ATP-MgC1 2 improved tubular function and inulin 
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clearance (GFR) 24 hours after 30 minutes of bilateral renal artery 
occlusion, and the degree of GFR was directly related to the quantity of 
ATP-MgC12 • Lyton et al. (235) also demonstrated improvement in renal 
function using ATP-MgC1 2 in the preserved and then transplanted dog 
kidney. ATP treated groups maintained lower serum creatinine and blood 
urea nitrogen levels, higher GFR and a greater osmolar clearance than 
untreated dog. ATP infusion increased renal cortical levels of ATP 
after prolonged ischemia (147). 
Many investigators have indicated that ATP improves organ 
function after 
restoration of 
hepatic ischemia. Chaudry et 
liver cell function and blood 
al. (75) demonstrated 
flow with ATP. They 
measured clearance of indocyanine green (ICG) at 3 hours following 
hepatic ischemia. ICG clearance was markedly depressed by ischemia but 
the ATP-MgC12 treated group had almost same ICG clearance value as the 
sham-operated animals. In a further study, the effects of ATP-MgC1 2 on 
mitochondrial function and hepatic ultrastructure were undertaken. ATP-
MgC12 treated group maintained high mitochondrial function--high ATP 
level, energy charge and respiratory control ratio--at 3 hours following 
reflow (266). Improved mitochondrial function by ATP following hepatic 
ischemia was also observed by Chaudry et al. (78). Three hours after 
hepatic ischemia and reflow, hepatic mitochondrial Ca+t and free fatty 
acids (FFA) levels increased and mitochondrial nucleotide translocase 
activity was depressed. However, ATP-MgC1 2 infusion resulted in lower 
FFA and Ca+t levels and restored nucleotide translocase activity to 
approximately 85% of normal. Chaudry et al. (78) suggested that 
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improved organ function with ATP may be mediated via improvement in 
mitochondrial function. In addition to liver tissue, ATP content in 
cultured myocardial cells, renal tissue and skeletal muscle after 
ischemia or hemorrhagic shock were also increased by ATP infusion (79, 
147' 346). 
Cell membrane transport of Na+ and K+ was depressed during 
hemorrhagic shock (21), but ATP-MgC12 restored normal membrane 
function. According to Ohkawa et al. (265), hepatic ischemia caused 
cell membrane dysfunction which led to cellular edema, high 
intracellular Na+ content and low intracellular K+ content; ATP-MgC1 2 
treatment improved cellular edema and electrolyte homeostasis. Serum 
glutamic oxaloacetic transaminase (SGOT) and serum glutamic pyruvic 
transaminase (SGPT) levels in the plasma were increased sixty minutes 
after total hepatic ischemia in rats which represent hepatic cellular 
damage or cell membrane disturbance. ATP-MgC1 2 administration following 
hepatic ischemia reduced both SGOT and SGPT levels (180). Kraven et al. 
(216) also demonstrated that treatment of hemorrhagic shock rat with 
ATP-MgC12 returned altered cell membrane permeability toward normal. 
Disturbances in glucose homeostasis which are characteristic of 
infection and endotoxicosis are prevented by ATP. Filkins and Ruchanan 
(126) demonstrated that ATP-MgC1 2 treatment protected the depression in 
postendotoxin gluconeogenesis and reduced glucose utilization ..!!!._ vivo 
and by epididymal fat pads. Chang and Cuatrecasas (71) and Chaudry and 
Gould (77) observed that ATP inhibited glucose transport and utilization 
in the adipocyte and isolated soleus muscle. Similar results were also 
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obtained in a in vivo study (125). The ATP effect on glucose uses may 
be due to modulation of insulin receptor. Since insulin binding to its 
receptor was inhibited by ATP in fat cells, liver cells and placental 
membranes (89, 332). 
In addition as reviewed recently by Chaudry (73), exogenous ATP-
MgC12 has beneficial effects via improvements in blood flow, improvement 
in metabolic capacity, restoration of reticuloendathelial cell function, 
restoration of cell membrane function and correction of hormone 
imbalance 
D. Hepatic Glycogenolysis 
1. HORMONAL STIMULATION OF GLYCOGENOLYSIS 
Hepatic glycogenolysis is stimulated by a variety of hormones, 
including catecholamines, glucagon, vasopressin, angiotensin II and 
oxytocin. Catecholamine-induced glucose output is mediated by 
two basic types of adrenergic receptor on the hepa tocyte-- a -
and S -adrenergic receptors ( 118, 179). Glycogenolysis as mediated 
through S -adrenergic receptors is associated with stimulation of 
adenylate cyclase and a subsequent increase in intracellular cyclic-
AMP. It is widely accepted that c-AMP is the second messenger which 
initiates a series of intracellular enzymatic reactions including 
cascade style activation of protein kinases; phosphorylase kinase and 
phosphorylase to result in an increased glucose output from the 
hepatocytes (324). 
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Many adrenergic receptor agonists and antagonists have been used 
to elucidate the regulation of glycogenolysis by catecholamines. 
Mayer et al. (240) demonstrated that dichloroisoproterenol 
(DCI), a 8 -receptor antagonist, almost blocked the increase in blood 
glucose by epinephrine, norepinephrine and isoproterenol in the dog. In 
contrast to DCI, phenoxybenzamine, a -receptor antagonist, did not 
interfere with epinephrine-induced hyperglycemia in the dog. Newton and 
Hornbrook (263) reported that propranolol completely abolished the 
increased phosphorylase activity induced by both isoproterenol and 
epinephrine in the dog liver. It is generally accepted therefore that 
catecholamine-induced glucose output due to glycogenolysis is mediated 
via a a-receptor mechanism in the dog. 
Several groups have, however, shown different results in rat 
models of catecholamine-induced glycogenolysis. Hutson et al. (187) 
demonstrated that epinephrine increased phosphorylase activity in 
isolated rat hepatocyte and phenoxybenzamine blocked epinephrine-induced 
phosphorylase activity but propranolol was not active. Similar results 
on a -adrenergic activation of hepatic glucose output in the rat have 
been observed in isolated rat parenchymal cells and in perfused rat 
liver (70, 117, 302). Ellis ( 114) reported that there are species 
differences in the glycogenolytic responses to catecholamines; 
catecholamine-stimulated glycogenolysis is mainly a-adrenergic receptor 
mediated in rat, mice, baboon and human whereas e-adrenergic receptors 
are dominant in dog and cat. It is also known that catecholamine-
induced glycogenolysis is dependent on sex difference, thyroid function, 
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and aging (35, 237, 319). Recently Itoh et al. (194) demonstrated that 
the adrenergic mechanism for phosphorylase activation was converted from 
an a- to S-type during 8 hours culture of rat hepatocyte. 
The dominant role for an a -adrenergic receptor merliated, cyclic-
AMP-independent mechanism for catecholamine action in rat liver has been 
supported by many laboratories including Exton et al. (31, 117, llR). 
Several investigators have shown that a -adrenergic stimulation resulted 
in changes in ca+t flux which coincided with glucose release. Blackmore 
et al. (33) demonstrated that infusion of phenylephrine increased Ca+t 
release from the perfused rat liver. This Ca+t release was blocked by 
phenoxybenzamine and was not affected by propranolol. Glucose output 
and phosphorylase activation by phenylephrine were impaired in isolated 
hepatocytes which were incubated in Ca+t free medium and it was 
increased by the ionophore A23187 (11, 209). Murphy et al. (254) also 
measured the changes in cytoplasmic free ca+t level and phosphorylase ~ 
activity after addition of phenylephrine and found a very close 
relationship between intracellular ca+t level and cyclic-AMP independent 
phosphorylase activity. 
Several calcium-pools exist in the liver including mitochondria, 
endoplasmic reticulum, plasma membrane and extracellular Ca+t. It is 
not well understood which ca+t-pool is the major source of the mobilized 
ca+t by catecholamines but there is much evidence that a -adrenergic 
stimulation mobilizes ca+t from mitochondria in the liver (34, 254). As 
described above the removal of Ca+t from incubation medium prevented 
activation of glycogen phosphorylase by catecholamines and ionophore 
28 
A23187 produced activation of phosphorylase. These findings indicate 
that ca++ influx from the extracellular fluid may contribute to increase 
++ cytoplasmic Ca levels. 
It is uncertain how catecholamines initiate ca++ entry from the 
extracellular space or ca++ release from intracellular stores. Michell 
(247) suggested that the hydrolysis of phosphatidylinositol by 
catecholamines is linked in some way with generation of signal for ca++ 
movement. Epinephrine increased 32P incorporation into phosphatidyl 
inositol and a -receptor antagonists (prazosin or phentolamine) blocked 
32p invotpotsyion, but propranolol did not (330). Exton (118) has 
proposed a more detailed hypothesis in which activation of a-adrenergic 
receptors lead to production of a hypothetical enzyme which open Ca++ 
gates in the plasma membrane and als~another hypothetical intracellular 
messenger lead to ca++ release from mitochondria or other intracellular 
Ca++ stores. Both of these processes result in increased cytoplasmic 
free ca++ which then combines with the ca++-dependent regulatory 
protein, calmodulin, and this ca++-calmodulin complex regulates 
phosphorylase activity. 
Glucagon is one of the most potent hepatic glycogenolytic 
hormones. In contrast to catecholamines, glycogenolysis by glucagon is 
principally and solely by a cyclic-AMP mediated process. The first step 
in initiation of a glucagon effect is hormone binding to the receptor. 
Although both glucagon and catecholamines stimulate adenylate cyclase in 
the liver, there are different receptors on the hepatocyte for each 
hormone. According to Newton and Hornbrook (263), propranolol blocked 
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completely the increased adenylate cyclase activity induced by 
epinephrine or isoproterenol but propranolol did not affect glucagon-
stimulated adenylate cyclase activity. This indicates the existence of 
separate receptors on the liver cell membrane for the glucagon and 
catecholamines. However, beyond binding to the receptor and activation 
of adenylate cyclase, cyclic-AMP is the common mediator of glucagon and 
epinephrine effects (121). Namely, the glucagon-receptor complex 
activates adenylate cyclase which generates the second messenger, 
cyclic-AMP. Cyclic-AMP then increases phosphorylase in the liver cell 
by converting phosphorylase b to phosphorylase a via cyclic-AMP 
dependent protein kinase and phosphorylase .£. kinase ( 120). 
Some hormones produce glycogenolysis in the liver which is not 
mediated by cyclic-AMP. Vasopressin increased glucose output in the 
perfused rat liver but it did not increase cyclic-AMP content in the 
liver ( 177, 215). Keppens and De'Wulf (210) reported that vasopressin 
increased phosphorylase activity but it did not affect any protein 
kinase or phosphorylase kinase. According to Hems et al. ( 178), the 
glucose release by vasopressin was critically dependent on ca++ in the 
medium. In ca++-free medium, vasopressin-stimulated glucose output did 
not occur. Angiotensin II and oxytocin have similar characteristics 
with vasopressin of a ca++ dependent activation of phosphorylase without 
mediation by cyclic AMP or protein kinase (177, 178, 211). These 
findings indicate that glycogenolysis by vasopressin, angiotensin II, 
and oxytocin is related to an elevation of intracellular ca++ similarly 
as a -receptor activation by catecholamines. 
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2. HYPOXIC STIMULATION OF GLYCOGENOLYSIS 
Hepatic glycogenolysis is sensitive to the oxygen tension in the 
liver. As oxygen delivery to the liver or isolated hepatocyte is 
limited, hepatic glycogenolysis is accelerated (175, 197, 301). The 
mechanism of hepatic glycogenolysis during hypoxia is completely 
different from those stimulated by hormones. As described above, 
hormones--catecholamines, glucagon and vasopressin etc.--stimulate 
hepatic glycogenolysis via cyclic-AMP mediation or changes in 
intracellular Ca++. However, hepatic glycogenolysis in the hypoxic 
condition is due mainly to changes in intracellular metabolite 
concentrations (179). 
Two forms of phosphorylase--phosphorylase ..!_ and b--exist in the 
hepatocyte (179). In normal states,- phosphorylase ~ is the main form 
which is subjected to allosteric regulations by ATP, AMP and glucose-6-
phosphate. Glycogenolysis is accelerated by AMP and inhibited by ATP 
and glucose-6-phosphate. Therefore, in a normal state of sufficient 
oxygen tension, hepatic glycogenolysis is suppressed due to high levels 
of intracellular ATP and low level of AMP. However, in hypoxia hepatic 
intracellular ATP content decreases while intracellular AMP, inorganic 
phosphate (Pi) and ADP increases. AMP content in particular increased 
dramatically in hypoxic liver (122, 175). Therefore, hepatic 
glycogenolysis in hypoxia is due to direct activation of phosphorylase 
activity via stimulation by a high level of intracellular AMP and 
deinhibition by a low level of ATP (179). 
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Free glucose is the main product of glycogenolysis in hypoxia but 
the hypoxic liver also produces lactate from glycogen via anaerobic 
glycolysis. Wood and Krebs (351) demonstrated that in anaerobic 
conditions perfused rat liver produced both lactate and glucose. 
Similar results have been obtained in isolated hepatocytes in that 
Seglen (301) demonstrated glycogen breakdown and lactate production 
during hypoxia. He also observed inhibition of lactate production by 
glucogon. 
E. Prostaglandin Action ~Metabolism and Hemoc'lynamics 
I. PROSTAGLANDIN SYNTHESIS AND RELEASE 
Prostaglandins are 20-carbon unsaturated oxygenated fatty acids 
that contain a cyclopentane ring. They appear to be present in every 
mammalian tissue and they cause a wide variety of physiological 
activities including smooth muscle contraction, 
platelets, and alterations in tissue metabolism. 
aggregation of 
Prostaglandin 
production begins when phospholipase A2 liberates arachidonic acids from 
phospholipid in the plasma membrane. Prostaglandins are synthesized 
from arachidonic acid by cyclo-oxygenase and additional specific enzymes 
for each prostaglandin. There are several prostaglandin families which 
are classified according to their configurations and substituents on the 
cyclopentane ring. It has been found that there are more than 16 
different prostaglandins which belong to 9 classes--they include PGA, 
PGB, PGC, PGD, PGE, PGF, PGG, PGH, and PGI. The major circulatory 
prostaglandins are PGE, PGF, PGA (thromboxane A), and PG! (prostacyclin) 
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series ( 206). 
Prostaglandins are not extensively stored in tissues but rather 
are synthesized ~ ~ and then released by suitable stimuli such as 
drugs, nerves and hormonal stimulation. Prostaglandin release has been 
demonstrated by chemical or nervous stimulation in rat phrenic nerve-
diaphragm preparation (285), in rat epididymal fat pads (306), and in 
rat gastric mucosa (24, 284). The release of prostaglandins or 
prostaglandin like substances is markedly enhanced during renal ischemia 
(112, 119, 242), during nerve stimulation (112), norepinephrine infusion 
(112), bradykinin addition (243) and infusion of angiotensin analogs 
(259). Prostaglandin release has also been demonstrated in perfused 
spleen by catecholamines, splenic nerve stimulation and by mechanical 
vibration (98, 149). In addition, the release of prostaglandins was 
reported in many other tissues including guinea-pig lung by anaphylaxis 
(279), cat cerebral cortex by electrical stimulation and human cultured 
endothelial cells by histamine and bradykinin (1). 
Adenine nucleotides are potent stimulators of prostaglandin 
release. According to Minkes et al. (252), ATP and ADP at 
concentrations of 1 x 10-7 to 10-6 moles stimulated release of 
prostaglandin like substances from hearts perfused with Krebs 
solution. Needleman et al. (260) also demonstrated prostaglandin 
release by ATP and ADP from various perfused organs--including rat 
liver, rabbit heart, spleen, kidney and fat pads. In addition, 
prostaglandin release with ATP or ADP was blocked by prostaglandin 
synthesis inhibitors. 
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There are many prostaglandin synthesis inhibitors and the 
responses to inhibitors vary greatly in different species and different 
organs. Flowers (130) reported the order of inhibitory potency of some 
aspirin-like prostaglandin synthesis inhibitor as follows: meclofenamic 
acid > indomethacin or niflumic acid > mefenamic acid ) flufenamic acid 
> naproxen > phenylbutazone > aspirin or ibuproten. According to Flower 
et al. (131) the r 50 of meclofenamic acid, indomethacin and aspirin was 
0.1, 0.17 and 37 uM, respectively. The mechanism of prostaglandin 
synthesis inhibitor action is not clear, however, several hypothesis of 
their actions have been proposed. It includes a competition at the 
substrate or cofactor site (327), irreversible inactivation of the 
synthesis enzyme (286), and a chelating action (311). 
2. PROSTAGLANDINS AND METABOLISM 
Prostaglandins affect cell metabolism either by modulation of the 
action of hormones or by direct action. The mode of action of 
prostaglandins is via changes in intracellular cyclic-AMP levels due to 
increased or decreased adenylate cyclase or phosphodiesterase 
activities. Prostaglandins E1 and E2 inhibited catecholamine-induced 
free fatty acid release in the dog (25, 26). A similar effect with 
prostaglandins has been observed using~ vitro studies. PGF. 1 and PGF.2 
inhibited the release of free fatty acid and glycerol from isolated rat 
epidiymal fat pads as stimulated by nerve stimulation or catecholamine 
addition (317). Butcher et al. (63) demonstrated reduction of cyclic-
AMP content by PGE 1 in isolated fat cells. Prostaglandins attenuated 
epinephrine, ACTH, glucagon and TSH-induced cyclic AMP levels. These 
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data indicate that the antilipolytic effect of prostaglandin is 
associated with a decrease in cyclic-AMP accumulation. 
In contrast to adipose tissue, prostaglandins of the F-series 
increase cyclic AMP levels and increase cell activity in various tissues 
including human platelets (290, 350), rat anterior pituitary gland cells 
(354), bovine corpus luteum (238), rat erythrocytes (308) and the 
thyroid gland of dogs and mice (47, 124). 
Prostaglandins also have effects on liver metabolism. Bohle and 
May (38) demonstrated that prostaglandin E1 injection (i.p.) produced 
hyperglycemia in fasted rats. In an in vitro study, they observed 
glycogen depletion in liver slices by addition of PGE 1 into the 
incubation medium. A hyperglycemic effect of PGE 1 was also demonstrated 
in the perfused rat liver (227). According to Hansson and Samuelsson 
(167), when they injected 3H-labelled PGE 1 into a mouse, the 3H PGE 1 is 
taken up primarily by liver, kidney, and uterus. This suggests those 
organs have high affinity binding sites to take up the prostaglandin 
from the blood. Smigel and Fleischer (313) found the presence of PGE 1 
receptor in plasma membrane of the rat liver. In a further study, they 
confirmed that only the plasma membrane of hepatocytes has an 
exclusively high affinity binding receptors, and other cell fractions 
such as nuclei, rough microsomes, Golgi complex or mitochondria have no 
high affinity receptors. 
Although the interaction of prostaglandin receptors and adenylate 
cyclase has not yet been fully understood, many studies suggest that 
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prostaglandin binding to the receptor leads to increased arlenylate 
cyclase activity in the hepatocyte. Many investigations have supported 
that prostaglandin E1 increased adenylate cyclase activity in the rat 
liver cell (267, 288, 289, 325, 347, 353). In addition, Robertson et 
al. (289) reported down-regulation of PGE receptors. When a dimethyl 
analogue of PGE2 was injected into the rat subcutaneously, the 
concentration of PGE receptors was significantly decreased with PGE-
induced plasma membrane adenylate cyclase. Up-regulation of hepatic PGE 
receptors was also reported (288). However, some controversy exists in 
that Levine (229) reported that PGE1 did not increase either hepatic 
cyclic-AMP activity or glucose output in the isolated perfused rat 
liver. Brass et al. (40) failed to demonstrate glycogenolysis by PGE 1 
in the isolated hepatocytes. Furthermore, dimethyl PGE2 inhibited 
glucagon-stimulated glycogenolysis. -
3. PROSTAGLANDINS AND VASCULAR RESISTANCE 
A prominant action of prostaglandins is regulation of vascular 
smooth muscle contraction. Different prostaglandins exert multiple 
hemodynamic changes in different preparations. The injection of PGE 1 or 
PGA1 into the coronary artery increased coronary blood flow in 
anesthetized dogs (255, 258). Vasodilator effects of PGE 1 have also 
been observed in such vasculature as the renal artery, femoral artery 
and carotid artery. PGE 1 elicits a biphasic change in portal vein 
resistance--initial increased followed by a decrease (257). In contrast 
to PGE 1, PGF2a increased vascular resistance in most vascular beds. 
Infusion of PGF2a increased portal venous pressure (257), pulmonary 
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arterial pressure (8), renal vascular resistance (256) and decreased 
utero-ovarian blood flow (278). 
Strong and Bohr (318) demonstrated_.!.!!. vitro that PGA1 , PGE 1 , PGE 2 
and PGFla caused contraction of isolated arterial strips from various 
rabbit arteries such as aorta, coronary artery, skeletal muscle artery, 
messenteric artery and renal artery. The prostaglandins also caused a 
biphasic response in canine small arteries with relaxation at low 
concentration and contraction at high concentration. 
ca++ ions are associated with the development of the contractile 
responses of smooth muscle to prostaglandins. Increased extracellular 
ca++ ion concentration enhanced the response to prostaglandins and 
reduction of ca++ concentration inhibited the prostaglandin responses 
(192, 271). According to Greenberg et al. ( 153), PGF 2:l increased 
norepinephrine, tyramine or high KCl-stimulated 45ca uptake in canine 
mesenteric arterial, mesenteric venous and tibial arterial strips. 
also increased 45ca efflux from those vascular smooth muscle 
preparations. PGA2 , however, increased 
45ca efflux from canine tibial 
but did not alter 45ca uptake, which may suggest PGA2 increases 
intracellular ca++ via release of ca++ from intracellular stores 
(154). Ishizawa and Miyazaki (191) also reported that the contractile 
mechanism of PGE 1 in guinea-pig stomach is mainly dependent on release 
of intracellular bound ca++ since verapamil markedly suppressed K+-
induced contraction but did not affect PGE1-induced muscle 
contraction. ++ Carsten (67) reported that PGE2 and PGF2a inhibited Ca 
binding to the sarcoplasmic reticulum of human uterine muscle and also 
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enhanced ca++ release from the microsomal fraction. 
The mechanism of prostaglandins action to increase ca++ influx or 
ca+t release from intracellular Ca++ stores is unclear. Due to 
similarity in the characteristics of prostaglandins and ionophores in 
ca+t release from uterine microsomes, Carsten and Miller (68) proposed 
an ionophoretic action of prostaglandins. Anderson and Kohn (5) 
suggested however that prostaglandins may increase ca++ permeability to 
the plasma membrane via activation of ca++ channel or acting as ca++ 
carrier. Thus, prostaglandins may transport ca++ ions across the plasma 
membranes by forming a PG-ca++ complex which is highly soluble in the 
lipid layer of the membrane. 
Prostaglandin mediation of the contractile response to ATP has 
also been reported. Indomethacin (20-50 uM) blocked rebound contraction 
of guinea-pig taenia coli induced by exogenous application of ATP or by 
purinergic nerve stimulation ( 57, 205). Indomethacin ( 3-20 uM) also 
depressed the contraction induced by ATP in rabbit detrusor (99, 105) 
and in isolated human umbilical artery (127). On the other hand, 
Burnstock et al. (60) demonstrated that ATP caused relaxation in the 
rabbit portal vein strip and indomethacin potentiated the relaxation 
induced by ATP. 
In summary, in reference to actions on vascular smooth muscle, 
prostaglandins are both stimulatory and inhibitory agents. The 
contractile responses to prostaglandins depend on the species of animal, 
the organ, the tissues and the prostaglandin type. ca++ ions may be 
involved in prostaglandin action. 
CHAPTER III 
METHODS 
A. Animals and Care 
-
Male albino rats of the Holtzman strain (300 to 350 gm) were used 
throughout this study. The rats were supplied from the Holtzman Company 
(Madison, Wi.) and were acclimated to our care facilities for 7 to 10 
days. All rats were housed in groups of three animals per cage with 
dimensions of 9.5" in length, 17" in width, and 7" in height. A 12 hour 
light-dark cycle (7:00 AM to 7:00 PM), ambient temperature of 22 to 26°C 
and 50% humidity were maintained. Rats were fed Wayne Lab Blox and tap 
water ad libitum. The nutrient composition of Wayne Lab Blox consists 
of 24.5% protein, 4.3% fat, 3.7% f-iber, 7.8% ash, with minerals and 
vitamins added. The gross energy of this preparation is 3.92 Kcal/gm. 
B. Preparation .2f_ Perfusion Solution and Apparatus 
1. SOLUTIONS 
a. Krebs-Ringer bicarbonate buffer (KRB) 
The perfusion medium was a standard Krebs-Ringer bicarbonate 
buffer solution except glucose was omitted. This solution contained (in 
mM) NaCl 117, KCl 4.7, CaC1 21.91, KH2Po4 1.19, MgS04 1.44 and NaHC03 
24.8. KRB was saturated with an o2/co2 (95:5 v/v) gas mixture and the 
pH was adjusted to 7.4 at 36°C. 
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b. ATP, ADP, AMP and adenosine 
ATP, ADP, and AMP (sodium salts 99%, Sigma) were prepared as 
stock solutions in a concentration of 50 mM in cold 0.9% NaCl. The pH 
was adjusted to 7 .1 to 7 .3 with 1 N Na OH. Adenosine was prepared 
likewise at a concentration of 10 mM. 
c. Glucagon 
2 x 10-5 M glucagon (Sigma) was prepared in saline as a stock 
solution. It was dissolved by adjusting the pH to 10 because of its 
poor solubility in acid and then re-titrated to 7.4 with 1 N HCl. 
d. Indomethacin 
2.8 mM indomethacin (Sigma) was prepared in KRB solution which 
contained 10% ethyl alcohol in order to facilitate dissolution. 
e. ATP-MgC1 2 and ATP-NaCl 
lOOmM of ATP, MgC1 2 and NaCl were prepared. The solutions, i.e., 
ATP and MgC1 2 or ATP and NaCl, were mixed in equal volumes. Thus, the 
concentration of ATP-MgC1 2 or ATP-NaCl after mixing was 50 mM 
respectively. 
2. APPARATUS 
A liver Perfusion-Aeration Apparatus from the MRA Corp. (M81-XL, 
22" x 15" x 40") was used for all perfusions. The arrangement of the 
perfusion components is shown in Figure 1. The perfusate was pumped 
from a perfusate reservoir by a Masterflex roller pump (Cole-Parmer 
Instrument Co.). It initially passed through a silk mesh filter (mesh 
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number 97, Sargent-Welch) which was changed everyday. From the filter 
the fluid moved to the gas exchange tube where the fluid was saturated 
with humidified o2/co2 (95:5) gas mixture. The perfusion medium was 
then passed through a second silk mesh filter by either another pump or 
a hydrostatic potential gradient. It then perfused the liver via the 
portal vein or hepatic artery. Flowmeters (Gilmont Instrument, Inc.) 
measured perfusion flow rates into the portal vein (Gilmont F-1300) and 
hepatic artery (Gilmont F-1200). Pressure transducers (Statham P23DC) 
measured portal vein perfusion pressure and hepatic arterial perfusion 
pressure which were recorded on Grass Polygraph (Model 79D). Changes in 
liver weight were measured by a force transducer (Grass FT03C). A pH 
meter (Beckman 76004) determined the pH of perfusate. Perfusate from 
the hepatic vein returned to the perfusate reservoir via a collection 
chamber. In this recirculating system, 130 ml of perfusion medium was 
recirculated every 2 minutes. The temperature in the perfusion cabinet 
and of the circulating medium was maintained at 36°C. A magnetic 
stirrer was placed below the floor of the cabinet to mix the perfusate 
in the perfusate reservoir. Several analyzing systems which were 
located outside of the perfusion cabinet were connected to the 
collection chamber. Figure 2 shows a schematic diagram of the analyzing 
system, including a K+ ion analyzer, a glucose analyzer, a lactate 
analyzer, a thermometer, an oxygen monitor, a pressure transducer and a 
force transducer. All of the analyzed information was recorded on a 
Linear Record (Linear Instrument Corp. Model 1200) and a Grass 
Polygraph. 
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FIGURE 1 
SCHEMATIC DIAGRAM OF LIVER PERFUSION SYSTEM 
All devices in the diagram except the roller pumps were located 
in the lucite perfusion cabinet at a regulated temperature of 36°C. 
Arrows represent directions of movements of perfusate and gas mixture. 
HA : hepatic artery; HV : hepatic vein; L : liver; PV : portal vein. 
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FIGURE 2 
SCHEMATIC DIAGRAM OF THE ANALYZING SYSTEMS 
All analyzers except the flow meter were located outside of the 
perfusion cabinet. Oinput and Ooutput represent oxygen tension of 
influent and effluent of perfusate to or from the liver respectively. 
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E..:.. Operative Technique and Perfusion Procedure 
1. OPERATION 
a. Perfusion through portal vein 
Most rats were used at 10:00 AM in the well-fed state. The rat 
was anesthetized with pentobarbital sodium (30 mg/Kg) via the dorsal 
vein of the penis. The abdomen was opened through a mid-line incision 
(10 to 12 cm). A mid-transverse incision to the left and right of the 
midline (6 to 7 cm) was then made, avoiding the large lateral blood 
vessels. The intestines were then placed to the animal's left, so that 
the liver, portal vein, right kidney and inferior vena cava were 
exposed. The inferior vena cava and portal vein were isolated and 500 
USP units of heparin were injected i.v. After ligating the abdominal 
vena cava above the renal vein, a PE-260 polyethylene catheter was 
inserted into the portal vein and tied in place with silk suture (size 
3-0). The liver was then rapidly flushed using about 20 ml of 0.9% 
saline. The thorax was opened by a transverse incision just above and 
along the line of the diaphragm and by a longitudinal cephalad 
incision. A PE-280 polyethylene catheter, cut off at a 45° angle to 
form a moderately sharp tip, was inserted and secured in the thoracic 
vena cava via penetration of the right atrium. The liver was rapidly 
excised, transferred onto a liver platform, covered with saline-
moistened gauze and placed in the perfusion chamber. The elapsed time 
between portal cannulation and restoration of flow was within 4 minutes. 
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b. Perfusion through hepatic artery 
After opening the abdomen, the coeliac artery and its branches--
the hepatic artery, superior pancreatico-duodenal artery and gastric 
artery--were isolated. All arteries which branched from the coeliac 
artery except the hepatic artery were ligated and a PE-50 polyethylene 
catheter was inserted and secured in the coeliac artery. The portal 
vein was then cannulated as described above. 
2. PERFUSION TYPES 
The liver perfusions were carried out in three ways as follows: 
a. Perfusion through the portal vein with a constant pressure 
(28 cmH2o). 
b. Perfusion through the portal vein with a constant flow 
(64 + 0.4 ml/min) using a roller pump. 
c. Perfusion through both the portal vein with constant 
pressure (28 cmH20) and the hepatic artery with constant 
flow (3.1 ±. 0.4 ml/min) using a roller pump. 
D. Measurements of Various Parameters in the Isolated Perfused Liver 
1. MEASUREMENTS OF GLUCOSE AND LACTATE PRODUCTION 
Glucose was measured on a Yellow Springs Instrument Model 26 
Glucose Monitor. The instrument is designed for the continuous 
monitoring of glucose using a glucose oxidase enzyme-hydrogen peroxide 
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probe. Samples were withdrawn continuously from the collection chamber 
of the liver perfusion apparatus with a thin polyethylene tubing (PE-10) 
and delivered to the reaction block of the monitor. Briefly, the 
principle of glucose determination by the glucose monitor is as 
follows. The tip of the glucose probe is covered by a three layer 
membrane. The outer membrane is composed of a polycarbonate material 
with relatively large pore size of 0 .03 u which allows diffusion of 
small molecules (glucose, lactate, oxygen, hydrogen peroxide, water and 
ions) but excludes enzyme protein. The inner membrane is a cellulose 
acetate material with much smaller pore size that excludes even glucose 
but still allows hydrogen peroxide, oxygen, water, ions etc. to 
permeate. Between these two membranes immobilized glucose oxidase 
exists in a thin layer of glutaraldehyde resin. Glucose in the sample 
diffuses through the outer membrane_and then is converted to gluconic 
acid and hydrogen peroxide under glucose oxidase by reaction 1. 
l. D-glucose + 02 _ _.g .... l_u_c_o_s_e_o_x_id_a_s_e___,~ 
The hydrogen peroxide then diffuses through the inner membrane anct is 
oxidized at a platinum anode by reaction 2. 
2. H2o2 ---------
The current thus generated is directly proportional to the glucose 
concentration in the sample. 
Lactate concentration was also measured on YSI Model 26 Monitor 
by exactly the same method and electrode principle but with a different 
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enzyme membrane and buffer. The probe consists of immobilized L-lactate 
oxidase and flavin adenine dinucleotide (FAD) between the outer anrl 
inner membrane. Lactate produces pyruvate and hydrogen peroxide under 
lactate oxidase and co-factors by reaction 3. 
3. Lactate + o
2 
__ L_-_l_a_c_t_a_t_e ____ o.,..x_i_d_a_s_e _ 
FAD 
pyruvate + H2o2 
The hydrogen peroxide diffuses through the inner membrane, and generates 
a current when it is oxidized at the platinum anode by the same reaction 
as in the glucose determination (reaction 2). 
Glucose and lactate production rates were calculated from glucose 
and lactate concentration changes of the perfusate as below: 
Glucose production rate (umoles/gm/hr) 
=A mg glucose/100 ml/5 min x 130 ml x 1000/180 umoles/mg x 60/5 x 1/gm 
where; A mg glucose/100 ml/5 min: changes in glucose concentration in 
the perfusate for 5 minutes after addition of ATP. 
130 ml: volume of total circulating perfusate. 
1000/180 umoles/mg: conversion factor to calculate umoles of 
glucose from mg of glucose. 
gm: liver weight after perfusion. 
60/5: conversion factor from minute to hour. 
Lactate production rate (umoles/gm./hr) 
= A mg lactate/100 ml/5 min x 130 ml x 1000/90 umoles/mg x 60/5 x l/gm 
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where; ~ mg lactate/100 ml/5 min: changes in lactate concentration. 
1000/90 umoles/mg: conversion factor from mg of lactate to 
umoles. 
The remaining terms of the expression were the same as in 
glucose calculation. 
2. MEASUREMENTS OF OXYGEN CONSUMPTION 
Oxygen tension was measured on Biological Oxygen Monitor (YSI 
Model 53). The oxygen probe was a Clark type polarographic electrode. 
The tip of the electrode is closed by a teflon FEP membrane with small 
amount of KCl solution. The membrane is permeable to gas (02) and 
allows them to enter the interior of the sensor. When a suitable 
polarizing voltage is applied across the probe oxygen will react at the 
cathode causing a current flow wh:i-ch is proportional to the oxygen 
pressure in the solution. Therefore, there is a linear relationship 
between external oxygen pressure and probe current. Two oxygen probes 
were employed--one at the site entering and the other at the site 
leaving the liver. In figure 2, Oinput and Ooutput represent oxygen 
tension differences between the two probes indicates oxygen uptake by 
the liver. Oxygen tensions were generally measured at 30 seconds 
intervals e.g. after addition of ATP for 10 minutes. Oxygen consumption 
rates were calculated from oxygen uptake and perfusion flow as follows: 
Oxygen amount in the solution: so2 (ul/ml) 
= a x P02 (a : 0.024 ml o2/ml of water/760 mmHg at 37°C) 
= 0.024 ml o2/ml of solution/760 mmHg x (760 x 95/100) mmHg 
= 0.0228 ml o2/ml of solution (=22.8 ul o2/ml of solution) 
Oxygen uptake by the liver: (ul/min) 
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= Oxygen amount in solution x Flow rate x Difference of 
saturation i. /100 
Oxygen consumption rate: (ul o2/min/gm) 
= Oxygen uptake by the liver x !/Liver weight (gm) 
3 • MEASUREMENTS OF K+ MOVEMENT 
K+ ion concentration in the perfusate was determined by an Orion 
Microprocessor Ionalyzer (Model 901). A K+ selective electrode (0rion 
Model 9319) was used in combination with a single junction reference 
electrode (Ag/AgCl reference electrode, Orion Model 9001). The 
electrode consists of an electrode body and a sensing module. The 
replaceable sensing module contains- an internal filling solution in 
contact with a porous plastic organophilic membrane. When the membrane 
is in contact with K+ ion, an electrode potential develops across the 
membrane. This potential, which depends on K+ ion concentration in 
solution, is measured against a constant reference potential of the ion 
analyzer. The measured potential corresponding to the K+ ion 
concentration is described by the Nernst equation and it is converted to 
direct K+ ion concentration by an internal computing program. 
E = E0 + s log (A) 
where; E measured electrode potential 
Eo constant reference potential 
A K+ ion concentration (in mM) 
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S electrode slope 
The electrode was placed in the effluent flow passing through the 
collection chamber which was located just behind liver and it was 
calibrated by known K+ standard solution before each experiment. 
Changes in K+ ion concentration were read at 30 second intervals. 
4. PERFUSION FLOW MEASUREMENT 
The perfusion rate was measured by calibrated spherical float 
flowmeter (Gilmont Instrument, Inc.). Gilmont Flowmeter F-1100 
(accuracy, + 2%) was used for measurement of portal vein perfusion flow 
and Gilmont Flowmeter F-1200 was also used to adjust and to maintain 
constant perfusion flow through the hepatic artery. The real perfusion 
flow rate (ml/min) was calculated from scale reading on the flowmeter 
via a calibration chart. 
5. PERFUSION PRESSURE MEASUREMENT 
Portal vein and hepatic arterial perfusion pressures were 
measured by Statham pressure transducers (P23DC). To measure changes in 
the perfusion pressure of the portal vein, the perfusion flow was 
maintained at 64 + 0.4 ml/min by a pump. Changes in hepatic arterial 
pressure were measured under constant flow (3 .1 + 0 .4 ml/min). In this 
case, the liver was perfused through the portal vein simultaneously with 
constant perfusion pressure. 
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6. MEASUREMENTS OF CHANGES IN LIVER CAPACITANCE 
After cannulation of portal and hepatic veins, the liver was 
transferred to a strain-gauge weighing device and perfused at a constant 
pressure. Changes in liver weight were measured with constant pressure 
(28 cmH2o) by a force-transducer (Grass FT03C) and Grass Polygraph. 
After completion of the perfusion, the wet liver weights were determined 
on a Mettler top-loading balance (Model P 1200). 
E. Measurements of Glucose and Lactate Production in the Isolated 
Hepatocytes 
1. ISOLATION OF HEPATOCYTES 
Hepatic parenchymal cells were isolated from fed rat livers by a 
modification of the method of Berry- and Friend (30). The liver was 
isolated by the same method as described above and then perfused with 
ca++ and glucose-free Hanks' (164) solution containing collagenase and 
hyaluronidase (Sigma). The perfusate contained (in mM): NaCl 117, KCl 
5.36, Na 2HP04 0.34, KH 2Po4 0.44, NaHC03 4.17, MgS04 0.41, MgC1 2 0.49, 
and collagenase 0.05% and hyaluronidase 0.1% adjusted to pH 7 .4. The 
liver was perfused in the recirculating system at a rate of 50 to 55 
ml/min under a constant hydrostatic pressure of 28 cmH2o. The enzyme 
digestion medium was oxygenated with 100% o2 and liver temperature was 
maintained at 36°C. After approximately 20 minutes of perfusion, the 
liver was disaggregated within the capsule and was carefully removed 
from the perfusion box and placed in a 100 ml Nalgene beaker. After 
adding 50 ml of cold perfusion medium, the diaphragm and blood vessels 
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~ere removed. The digested liver was cut into very small pieces to aid 
the dispersion of the cells. In order to disperse the remaining tissue, 
the liver cell suspension was divided into two portions and each portion 
placed in a 250 ml Nalgene Erlenmeyer flask. After gassing with 100% o2 
for 1 minute, the liver cells were incubated for 15 minutes at 37°C in a 
Dubnoff metabolic shaker bath at 100 oscillations per minute. At the 
end of the incubation, the hepatocyte suspension was then sequentially 
filtered through three folds of sterile surgical gauze and 100-mesh silk 
screen into 50 ml Nalgene centrifuge tube in the ice box. Intact 
hepatocytes were separated from cellular debris, damaged cells, and 
Kupffer cells by centrifuging at 50 x g for 3 minutes at 4°C. The cell 
pellet was washed three times with buffer (two times with Ca* and 
glucose-free Hank's solution and one time with glucose-free KRB buffer 
solution). The isolated hepatocytes were filtered again and finally 
resuspended in a 40 ml of cold glucose-free KRB buffer. Protein 
concentration of the hepatocyte suspension was determined by the method 
of Lowry et al. (1951) using a Beckman Spectrophotometer (Acta C3). 
2. INCUBATION AND ASSAY 
6 ml of the hepatocyte suspension was incubated at a 
concentration of 2.45 + 0.25 mg of protein/ml in 25 ml Erlenmeyer 
flasks. Incubation was conducted at 37°C in a Dubnoff metabolic shaker 
bath at 60 oscillations/min and continuously gassed with water-saturated 
95% o2/5% co2 for 60 minutes. At O, 10, 20, 30, 40, 50 and 60 min of 
incubation, 0.2 ml of incubation mixture were placed into Beckman 
microfuge tubes in ice, centrifuged in a Beckman 152 Microfuge for 30 
54 
seconds and frozen in the freezer. Glucose and lactate concentrations 
in the supernatant were measured using the glucose oxidase and lactate 
oxidase methods in the YSI 23A Glucose Analyzer and YSI 231 Lactate 
Analyzer respectively. 
F. Statistical Analysis 
Results are presented as mean + standard error of the mean (Mean 
+ S .E .M.). The statistical significance of the data was determined by 
Student's t-tests for paired or unpaired observations. Significance was 
accepted at p <0.05. 
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CHAPTER IV 
RESULTS 
A. Effects of ATP on Glucose and Lactate Production Rates in the 
-
Isolated Fed Perfused Liver 
1. GLUCOSE PRODUCTION UNDER CONSTANT PERFUSION PRESSURE 
Since the KRB solution used in these experiments initially 
contained no glucose, the glucose concentration measured in the medium 
prior to starting hepatic perfusion was zero. The glucose concentration 
of the perfusate rapidly increased early in the perfusion probably due 
to glycogenolysis; the rate however showed a saturation point after 20 
min to 30 min (Fig. 3). Thirty minutes after perfusion ATP (26 ul of 50 
mM) was added into the perfusate reservoir to achieve a concentration of 
10 uM. 40 uM and 160 uM concentration of ATP were then achieved at 15 
min and 30 min after the first addition of ATP. 
As shown in Fig. 3 glucose concentration in the perfusate was 
increased by addition of ATP and the magnitude of increase was 
proportional to the ATP concentration. Fig. 4 depicts the effects of 
ATP on glucose production rates (umoles/gm/hr) under constant portal 
perfusion pressure. As the concentration of ATP in the perfusate was 
increased from 0 (basal) to 10 uM, 40 uM and finally 160 uM, the glucose 
production rates were significantly increased from 52 .5 .::!:. 3 .5 (basal) to 
86.5 + 4.1 (P<0.05), 121.0 + 7.1 (P<0.001) and 197.0 + 17.4 (P<0.001), 
55 
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FIGURE 3 
RECORDING OF CHANGES IN GLUCOSE AND LACTATE LEVELS 
DURING PERFUSION OF THE LIVER 
The rat liver was perfused through portal vein with recirculating 
KRB solution under a constant perfusion pressure . of 28 cmH2o. The 
glucose and lactate levels were continuously and simultaneously measured 
and recorded. ATP was added into the perfusate reservoir at 30, 40, and 
55 minutes of perfusion. 
, . , I l ; ' ',, I I I l I I '(T: 
·---- ... .=, 
-
'O 
....... 
m 
E 
60 . ~·:t't~rr--. r ,-1 F -, , ! 
30 i i l 1 r +-r 1 · , : : 
1 
• , ,.,- -----:· 
-~- --1--1~-t-t- -t --r- -r-- f- -, - 1 ·~ --· -
-
CJ• I l ' I-· I I I . I 
I I ' ' I ' I c I ' I I 
0 '01 ! ' I ~ 0 -:- , r ~ r~~rr 'r~ ~·n 1 ,- 'i" 
~ 200 .. ~.J~~d-t--~, il' ! . ·~ ! ' ~ -r l · 1·· l ·1 - I . I I I 
oa -IL. . r ---1~ -· r -· 1 ·-·· 11- !Ill I -
e ··-.·- ! · !· I . i ~ 1 oo - . +--1 ___ 1'~- __ II·---· f-- _I ___ ,_ 
CJ , I ' 
= , 1 ·, I -CJ : • I 1 i ! 
-7-···;o··-1---l--1-- : __ -!---,- i 
. :~: 
------4 
-· 1 - \ I - I --· I : 
0 .... .._ ____ ~-· ..... 1,.....1 __ .1 ____ .-------..... -'------..., ...... -------,..--------
0 15 30 45 60 75 
Time ( min ) \J1 
-..J 
58 
FIGURE 4 
EFFECTS OF ATP ON GLUCOSE PRODUCTION UNDER CONSTANT 
PERFUSION PRESSURE 
Mean + S .E .M. of glucose productin rates for control and ATP 
additions are presented. Number of experiments is indicated in 
parentheses. * denotes P<0.05 and ** denotes P(0.001 compared to 
control. 
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respectively. 
2. GLUCOSE PRODUCTION UNDER CONSTANT PERFUSION FLOW 
When ATP was added to the perfusate, perfusion flow was 
decreased. Thus, the reduction in perfusion flow might have affected 
glycogenolysis by limitation of oxygen delivery and therefore explain 
the effects of ATP on glucose production. To test the possibility that 
the glycogenolytic effect of ATP was due to the low perfusion flow, 
livers were perfused through the portal vein with a constant flow (64 + 
0.4 ml/min) and the effects of ATP on glucose production were 
observed. 
Fig. 5. 
The results of the constant flow experiments are shown in 
In general, glucose production rates in response to ATP 
additions under constant perfusion flow were lower than under constant 
perfusion pressure (Fig. 4 and 5). However, ATP still increased glucose 
production significantly and in proportion to its concentration i.e., 
control: 43.2 + 3.4; 10 uM 63.1 + 3.7, P(0.05; 40 uM : 91.3 + 7.9, 
P<0.001; and 160 uM ATP : 130.4 + 11.7, umoles/gm/hr, P<0.001. These 
findings indicate that the low perfusion flow induced by ATP is not the 
sole factor which increased glucose production in the perfused liver. 
3. LACTATE PRODUCTION UNDER CONSTANT PERFUSION PRESSURE 
As shown in Fig. 3, lactate concentration in the perfusate was 
increased progressively during the perfusion. The rate of appearance of 
lactate was slow during initial 0 to 10 minutes of perfusion, then it 
increased progressively. The rate of lactate appearance was lower than 
that of glucose. Thirty minutes after perfusion three different 
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FIGURE 5 
EFFECTS OF ATP ON GLUCOSE PRODUCTION UNDER CONSTANT 
PERFUSION FLOW 
Livers were perfused with constant flow of 64 + 0.4 ml/min. 
Means + S.E.M. of glucose production rates for control and ATP additions 
are presented. Number of experiments is indicated in parentheses. * 
denotes P<0.05 and ** denotes P(0.001 compared to control. 
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concentrations of ATP were added into the perfusate reservoir by the 
same means as in the section on glucose production (A-1). Lactate 
production was increased by the ATP added in proportional to its 
concentration. After reaching a peak, the concentration of lactate 
progressively declined. This may be due to use of the lactate for 
gluconeogenesis as a substrate by the liver. The pH of the perfusate 
was decreased by addition of ATP for a few minutes and then it was 
recovered. This may be due to an increase in lactate concentration. 
The rates of lactate production (umoles/gm/hr) by O, 10, 40, and 160 uM 
ATP were 34.6 + 4.9, 44.0 + 8.6, 63.2 + 3.5 (P<0.01), and 91.9 + 4.6 
(P<0.001) respectively (Fig. 6). 
B. Effects of ATP on glucose and lactate production rates in the 
hepatocytes isolated from fed .!!!_ 
1. GLUCOSE PRODUCTION RATE 
In order to assess a direct effect of ATP on glycogenolysis in 
the liver, ATP was next evaluated in hepatocytes isolated from fed rat 
livers. During incubation of hepatocytes at 37°c, glucose production 
was measured both with and without ATP (SO and 200 uM) in the incubation 
medium. Glucagon ( 10-6M) was also added to confirm whether this cell 
system responded to a known glycogenolytic agent. Fig. 7 illustrates 
the time course of glucose output of the isolated hepatocytes during 
incubation under the following conditions: presence of 50 uM ATP, 200 uM 
ATP, 10-6 M glucagon and glucagon (10-6M) plus ATP (200 uM). 
The effects of ATP on glucose production rates in the isolated 
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FIGURE 6 
EFFECTS OF ATP ON LACTATE PRODUCTION IN THE PERFUSED LIVER 
Livers were perfused under constant perfusion pressure of 28 
cmH20. Means + S.E.M. of lactate production rates for control and ATP 
additions are presented. Number of experiments is indicated in 
parentheses. 
control. 
* denotes P<0.01 and ** denotes P<0.001 compared to 
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he pa tocytes are presented in Fig. 8. Fifty uM ATP tended to decrease 
glucose production but the change was not significantly different from 
control (P>0.1); however, 200 uM ATP actually inhibited glucose 
production significantly (control 0.575 + 0.034; 50 uM : 0.5::10 + 
0.029; 200 uM: 0.475 .±. 0.027 umoles/mg protein/hr, P(0.05). Glucagon 
(10-6M), however, stimulated glucose production two fold as compared to 
controls. ATP inhibited glucagon-stimulated glucose output (10-6M 
glucagon : 1.146 + 0.059; glucagon (10-6M) plus ATP (200 uM) 0.802 + 
0.027, P(0.001). These results indicate that ATP does not directly 
increase glycogenolysis in the hepatic parenchymal cells and indeed may 
inhibit net glucose production. 
2. LACTATE PRODUCTION RATE 
Lactate production is genera-fly considered as an indicator of 
glycogenolysis and subsequent glycolysis during hypoxic states. 
Therefore, the effects of ATP on lactate production were studied in 
isolated hepatocytes (Fig. 9). Lactate production increased linearly 
during incubation of control hepatocytes. The increase after 40 min 
subsequently diminished progressively. As shown in Fig. 10, exogenous 
ATP diminished lactate production (control : 0.434 + 0.041, 50 uM : 
0.361 .±. 0.039, 200 uM ATP : 0.171 + 0.031, P(0.001). Glucagon almost 
completely inhibited lactate production and ATP failed to alter the 
inhibitory response. These results also indicate that ATP has no direct 
stimulating effect on glycogenolysis in hepatic parenchymal cells. 
67 
FIGURE 7 
TIME COURSE OF GLUCOSE PRODUCTION IN ISOLATED HEPATOCYTES 
Hepatocytes were isolated from fed rat liver and incubated in KRB 
at 37°c. ATP and glucagon were added at 0 minutes of incubation time. 
Glucose concentration in the medium was measured at 10 minutes intervals 
for 60 minutes of incubation. Protein concentration in each flask was 
2.45 mg/ml. Means + S.E.M. are depicted. 
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FIGURE 8 
EFFECTS OF ATP ON GLUCOSE PRODUCTION RATES IN THE 
ISOLATED HEPATOCYTES 
Means + S .E .M. of glucose production rates for control, ATP, 
glucagon and glucagon plus ATP are presented. Number of experiments is 
indicated in parentheses. * denotes P<0.05, ** denotes P<0.0005 
compared to control and *** denotes P<0.001 compared to glucagon 
addition. 
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FIGURE 9 
TIME COURSE OF LACTATE PRODUCION IN 
ISOLATED HEPATOCYTES 
Lactate concentration in the medium was measured in the same 
samples used to determine glucose production in Figure 7. Means + 
S.E.M. are depicted. 
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FIGURE 10 
EFFECTS OF ATP ON LACTATE PRODUCTION RATES 
IN THE ISOLATED HEPATOCYTES 
Means + S.E.M. of lactate production rates for control, ATP, 
glucagon, and glucagon plus ATP are presented. Number of experiments is 
indicated in parentheses. * denotes P<0.005, ** denotes P<0.001 
compared to control and *** denotes P>0.05 compared to glucagon 
addition. 
74 
0.5 
-
* 
{ N = 8) 
.. 
.c 
CJ, 0.4 I ~ E ' "' I G> -0 E I I :I 0.3 - I G> I .. CV I .. I c 0 I ~ 0.2 I ~· u :I 't7 I I 0 .. Q. I G> I I 'S I .. 0.1 I u I CV .... I I I 
** 0 
-6 
Control ATP ATP Glucagon Gluc.10 M 50uM 200uM 10-6M +ATP 200uM 
75 
.£!_ Effects ~ATP _£!!. Oxygen Consumption ~ the Perfused Liver 
It is possible that endothelial cell injury occurs at high 
perfusion flow, while the tissue falls into a hypoxic state at low 
perfusion flows (297). Therefore, it is important to maintain an 
adequate perfusion flow to prevent either cell injury or hypoxia 
particularly in erythrocyte-free perfusion system which requires high 
perfusion flow rate. Oxygen consumption of the perfused liver was 
calculated from perfusion flow and oxygen extraction measurements (see 
Methods Section, pp ). As the perfusion flow increased from 25 ml/min 
to 65 ml/min, oxygen extraction (02 tension difference of the perfusate 
entering and exiting the liver) decreased. However, oxygen consumption 
rates increased as the perfusion flow increased; due to the fact that 
the percent increase in perfusion flow was higher than the decrease of 
oxygen extraction (Fig. 11). Therefore, in the present studies livers 
were perfused at a flow rate of 60 to 65 ml/min; this was the range at 
which oxygen consumption was saturated. 
Fig. 12 presents hepatic oxygen extraction rates at varying doses 
of ATP. The bottom line (point a) represents the oxygen tension of the 
effluent during the perfusion period. Point b represents the oxygen 
tension of the influent at the same time. Therefore, the differences of 
oxygen tension between influent and effluent (points b - a) indicate 
oxygen extraction by the liver. ATP (10 uM) increased oxygen 
extraction. However, oxygen extraction at high concentrations of ATP 
( 40 and 160 uM) exhibited a biphasic course with an early decrease in 
oxygen extraction followed by a later increase in oxygen extraction. 
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FIGURE 11 
RELATIONSHIP BETWEEN PERFUSION FLOW AND OXYGEN 
TENSION DIFFERENCE OR OXYGEN CONSUMPTION RATES 
Portal vein perfusion flow was regulated by adjusting flow with a 
tubing clamp during a constant perfusion pressure of 28 cmH20. Means + 
S.E.M. are depicted. 
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FIGURE 12 
CHANGES IN OXYGEN TENSION IN THE PERFUSATE DURING 
PERFUSION WITH ATP 
Livers were perfused with oxygenated KRB under a constant 
perfusion pressure of 28 cmH20. Oxygen tensions in the influent and 
effluent perfusion fluid were monitored with two oxygen probes. Oxygen 
tension of the effluent was recorded continuously and that of influent 
was read at proper times using a probe-selection swtich. Point a 
represents the oxygen tension of the effluent and point b represents the 
oxygen tension of the influent at the same time. 
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FIGURE 13 
EFFECTS OF ATP ON OXYGEN CONSUMPTION RATE 
Left figure (A) represents the effect of ATP on oxygen 
consumption rate in the perfused liver. Right figure (B) represents % 
changes in oxygen consumption rate by ATP. Each point represents mean + 
S.E.M. from 6 liver. 
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Fig. 13-A depicts the effects of ATP on oxygen consumption. Al though 
ATP decreased perfusion flow, the increment of oxygen extraction after 
10 uM ATP was relatively greater than the reduction of perfusion flow, 
such that the oxygen consumption rate was increased at low 
concentrations of ATP. However, high doses of ATP (40 and 160 u'M) 
decreased both perfusion flow rate and oxygen extraction. Consequently 
40 uM and 160 uM ATP decreased oxygen consumption in the early phase. 
Two to 5 min after ATP addition the perfusion flow recovered to the 
original level but oxygen extraction still remained increased. These 
factors caused a resultant high oxygen consumption in the late phase. 
Fig. 13-B presents percent changes in oxygen consumption by addition of 
ATP. The peak changes in oxygen consumption (in %) by 10 u'M, 40 uM and 
160 uM ATP were +15.2 (P<0.05), -39.5 (P<0.05) and -86.9 (P<0.001), 
respectively. 
D. Effects of ATP on K+ Movement in the Perfused Liver 
A transient release and uptake of K+ occur concomitantly with 
glucose output when the liver is stimulated by either hormones or other 
stimuli such as hypoxia (171, 294). K+ concentration in effluents were 
measured at 30 sec intervals with a K+ ion-sensitive electrode. Fig. 14 
shows K+ movement after addition of ATP. K+ was apparently extracted by 
the liver during the first 1 min after addition of ATP (in 10 uM or 40 
uM). The initial extraction was immediately followed by a K+ release 
which reached a maximum at 4 to 5 min after ATP. The peak K+ 
concentrations in mM of the perfusate after ATP were 5.06 + 0.08, 5.33 + 
0.12 (P<0.05) and 5.62 + 0.10 (P<0.05) at 10 uM, 40 uM and 160 uM ATP, 
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FIGURE 14 
EFFECTS OF ATP ON K+ MOVEMENT IN THE 
PERFUSED RAT LIVER 
K+ was continuously measured in the effluent from the liver using 
ion-selective electrodes. After 30 minutes of perfusion 10 uM ATP was 
added. 40 uM and 160 uM ATP were added at 45 and 60 minutes of the 
perfusion. Each point represents mean+ S.E.M. from 6 livers. 
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respectively. K+ was subsequently taken up again, such that the K+ 
concentration of the perfusate declined to the original level. 
E. Effects of ATP on Hepatic Circulation in the Isolated Liver 
Preparation 
1. ATP ON PORTAL VEIN PERFUSION FLOW 
Changes in perfusion flow in the portal vein under constant 
perfusion pressure (28 cmH20) were measured. After a 30 min stabilizing 
period, 10 uM, 40 uM and 160 uM ATP were added into the perfusate and 
perfusion flows were determined at 30 sec intervals. As depicted in 
Fig. 15, ATP decreased perfusion flow in proportion to its concentration 
with the lowest values achieved at 1 - 1.5 min after ATP. The maximum 
reductions of perfusion flow were 16.8%, 27 .3% and 43. 7% at 
concentrations of 10 uM, 40 uM and 160 uM of ATP, respectively. The 
perfusion flow subsequently recovered to the original flow and the 
recovery time was directly proportional to the ATP dose. 
2. ATP ON PORTAL VEIN PERFUSION PRESSURE 
Fig. 16 depicts a representative record of the effects of ATP on 
portal vein pressure changes under constant flows of 64 + 0.4 ml/min. 
Three different concentration of ATP (10, 40, and 160 uM) were added 
into the perfusate reservoir. ATP increased portal vein pressure 
significantly. ATP effects occurred within 30 sec and the portal vein 
pressure reached a maximum level at 1 or 1.5 minutes after ATP 
addition. The results of 8 similar experiments (Fig. 17) indicated 
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FIGURE 15 
EFFECTS OF ATP ON PERFUSION FLOW VIA THE 
PORTAL VEIN 
Livers were perfused with KRB under a constant perfusion pressure 
of 28 cmH2o. After 30 minutes of perfusion ATP was added into the 
perfusate reservoir. Each point represents mean + S .E .M. from 14 
livers. 
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FIGURE 16 
RECORDING OF CHANGES IN PERFUSION PRESSURE 
IN THE PORTAL VEIN 
Portal vein perfusion pressures were measured under a constant 
perfusion flow of 62 ml/min. lOuM ATP was added at 30 minutes of 
perfusion. 40uM and 160uM ATP were added at 40 and 50 minutes of 
perfusion. 
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FIGURE 17 
EFFECTS OF ATP ON PERFUSION PRESSURE 
OF THE PORTAL VEIN 
Each point represents means + S.E.M. from 8 livers. 
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changes of portal vein pressure (mmHg) after ATP addition of 16.8 at 10 
uM, 20.3 at 40 uM and 23.7 at 160 uM. At low concentration of ATP (IO 
uM) the increased portal vein pressure returned to control level within 
about 3 minutes but at higher concentration (40 and 160 uM) the recovery 
time was increased to 7 and over 10 min, respectively. 
3. ATP ON HEPATIC ARTERIAL PERFUSION PRESSURE 
Hepatic arterial perfusion pressure changes were measured under a 
constant arterial perfusion flow of 3.1 + 0.4 ml/min. In addition 
livers were also perfused through the portal vein at about 60 ml/min 
flow. Hepatic arterial perfusion pressure was maintained about 77 mmHg 
before addition of either ATP or saline--as a vehicle control. Saline 
(0.5 ml) or ATP was injected into the inlet of the hepatic artery at 10 
cm ahead of the liver. Fig. 18 -shows a typical record of he pa tic 
arterial pressure response to saline and ATP. Saline injection produced 
a brief hepatic arterial pressure change for a few seconds; this is 
probably an artifact of the saline injection. Two different amounts of 
ATP (5 umoles and 25 umoles) were then injected into the tubing in the 
same manner as for saline and the perfusion pressure changes were read 
at 20 sec intervals after addition of ATP. As ATP was injected through 
the hepatic artery, the injection artifact was followed by a prominent 
increase in hepatic arterial perfusion pressure. The magnitude of the 
hepatic arterial pressure increments and the duration of ATP action were 
proportional to the amounts of ATP added. As summarized in Fig. 19, 5 
umoles of ATP increased hepatic arterial pressure from 77.1 + 2.4 to 110 
+ 8.4 mmHg (P<0.005) at 20 sec after ATP injection. ATP (25 umoles) 
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FIGURE 18 
RECORDING OF CHANGES IN HEPATIC ARTERIAL 
PERFUSION PRESSURE 
Hepatic arterial pressure was measured under a constant perfusion 
flow of 3 .1 ml/min. Liver was perfused simultaneously through the 
portal vein with a constant perfusion pressure of 28 cmH20. Saline and 
ATP were injected into the inlet of hepatic artery at 10 cm proximal to 
the liver. 
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FIGURE 19 
EFFECTS OF ATP ON PERFUSION PRESSURE IN THE 
HEPATIC ARTERY 
Each point represents mean+ S.E.M. for 7 livers. 
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increased hepatic arterial pressure from a control of 76. 9 + 2 .1 to 
150.4 + mmHg at 40 sec (P<0.001). Thus ATP increased the resistance of 
both the portal vein and hepatic arterial systems. 
4. ATP ON LIVER CAPACITANCE 
There are two major sphincteric sites in the hepatic circulation 
--i) inlet sphincters which are located at the junction of the sinusoids 
with the portal venules and ii) outlet sphincters which are located at 
the junction of the sinusoids with the central venules (241). The 
hypothesis of this study was that if ATP acted on the inlet sphincter 
region, it should decrease liver capacitance (weight); however, if ATP 
acted on the resistance of the outlet sphincter region, it should 
increase liver capacitance. To test the hypothesis liver weight changes 
were measured during perfusion. Aft~r a 30 min stabilizing period, ATP 
was added into the perfusate reservoir and liver weight changes were 
recorded. Fig. 20 presents an example of liver weight changes at three 
different ATP concentration. ATP transiently decreased liver weight in 
proportion to its concentration. Liver weights then recovered to 
original levels--the recovery period was proportional to the ATP dose. 
Results of seven experiments are summarized on Fig. 21. Liver weights 
reached minimum levels within 1 or 1.5 min after addition of ATP. ATP 
decreased liver weights from 12.5 + 0.50 to 11.9 + 0.52 at 10 uM 
(P>O.l); to 10.9 .::!:. 0.48 at 40 uM (P<0.05); and to 9.9 + 0.5 at 160 uMATP 
(P<0.01). Linear regression analysis (Fig. 22) was performed to 
determine any correlation between changes in perfusion flow (ml/min) and 
changes in liver weight (gm). The equation of the regression line was 
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FIGURE 20 
RECORDING OF CHANGES IN LIVER WEIGHT DURING 
PERFUSION 
Liver weight was measured with a constant perfusion pressure of 
28 cmH20. The force transducer was calibrated in the presence of the 
liver by adding or removing calibrated weights. ATP was added into the 
perfusate reservoir. 
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FIGURE 21 
EFFECTS OF ATP ON LIVER CAPACITANCE 
Each point represents mean+ S.E.M. of 7 livers. 
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FIGURE 22 
RELATIONSHIP BETWEEN CHANGES IN PERFUSION FLOW 
AND CHANGES IN LIVER WEIGHT 
Linear regression analysis indicates a significant correlation 
between changes in perfusion flow (ml/min) and changes in liver weight 
(gm) (r = 0.983, P<0.001). 
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y = 0.094 x + 0.087. The correlation coefficient, r, was 0.983 and 
indicates a significant correlation (P<0.001) between changes in 
perfusion flow and changes in liver weight. 
F. Comparison .£f_ Adenine Nucleotides and Ade no sine on Perfusion Flow, 
Oxygen Consumption and Glucose Production 
Perfusion flow changes were measured under a constant perfusion 
pressure of 28 cmH20 and then 50 uM of adenosine, AMP, ADP and ATP, 
respectively were added into the perfusate. As depicted in Fig. 23, the 
magnitudes of the flow reductions were different. Adenine derivatives 
decreased perfusion flow in the following order: ATP > ADP > AffP = 
adenosine. Changes in perfusion flow at 1 min after addition of each 
agent were as follows: 63 .1 + 1 .14 of control to 58 .O + 1.39 ml/min for 
adenosine (P<0.01), from 64.0 + 0.-96 to 59.6 + 1.09 ml/min for AMP 
(P<0.01), from 63.9 + 0.67 to 47.6 + 1.5 for ADP (P<0.001) and from 64.0 
+ 0.96 to 44.4 + 1.29 for ATP (P<0.001). 
Adenosine and AMP did not significantly decrease oxygen 
consumption (ul02/gm/min) -- the changes were from 55.5 + 3.1 to 51.6 + 
3.3 for adenosine (P>0.1), from 57.3 + 2.5 to 54.6 + 3.0 for AMP 
(P<0.1). However ADP as well as ATP significantly decreased oxygen 
consumption; the changes were from 58.2 + 2.4 to 44.8 + 2.9 for ADP 
(P<0.005) and from 56.5 + 2.2 to 40.5 + 1.7 for ATP (P<0.001). 
Fifty uM of adenosine, AMP, ADP and ATP increased glucose 
production in the perfused liver. The glucose production rate changes 
(umoles/gm/hr) for each agent were from 51.8 + 8.0 to 78.7 + 8.5 for 
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FIGURE 23 
COMPARISON OF ADENINE NUCLEOTIDES AND ADENOSINE 
ON PERFUSION FLOW 
Livers were perfused under a constant perfusion pressure of 28 
cmH20. Each point represents mean+ S.E.M. for 12 livers. 
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FIGURE 24 
COMPARISON OF ATP-MgC1 2 WITH ATP-NaCl ON 
PERFUSION FLOW 
Livers were perfused under constant perfusion pressure of 28 
0 .26 ml of 50 mM ATP-MgC1 2 or ATP-NaC12 was added into the 
perfusate alternately. Each point represents mean + S.E.M. for 8 
livers. 
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FIGURE 25 
COMPARISON OF ATP-MgC12 WITH ATP-NaCl ON 
OXYGEN CONSUMPTION RATE 
Liver perfusion conditions and ATP addition were as described in 
Figure 24. Each point represents mean + S.E.M. for R livers. 
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adenosine (P<0.05), from 49.8 + 7.0 to 77.0 + 10.7 for AMP (P<0.05), 
55.5 + 9.1 to 120.4 + 7.0 for ADP (P<0.001) and from 58.4 + 11..6 to 
138.9 + 11.6 (P(0.001) for ATP. 
In addition, the effects of ATP-NaCl and ATP-MgC1 2 on perfusion 
flow and oxygen consumption were also compared. Changes in portal vein 
perfusion flow with a constant perfusion pressure (28 cmH20) were 
measured. One hundred uM ATP-NaCl or ATP-MgC12 was added into the 
perfusate and perfusion flows were determined at 30 sec intervals. As 
depicted in Fig. 24, both ATP-NaCl and ATP-MgC12 decreased perfusion 
flows with lowest values achieved at 1 min after ATP addition. Fig. 25 
depicts the effects of ATP-NaCl and ATP-MgC12 on oxygen consumption rate 
in the perfused liver. A biphasic response to ATP occurred with a 
decrease in oxygen consumption initially and an increase later. Thus, 
these findings indicate that there is no difference between ATP-NaCl and 
ATP-MgC12 on either perfusion flow in the portal vein or oxygen 
consumption. 
G. Effects of Indomethacin on ATP-induced Perfusion Pressure, Perfusion 
Flow and Glucose Production 
In this study, portal vein pressure was maintained about 13 mmHg 
with constant perfusion flow. After a 30 min stabilization period, 20 
uM ATP and then 20 uM indomethacin were added to the perfusate. Ten or 
15 min after indomethacin treatment, the same amount of ATP (20 uM) was 
added again and portal vein pressure changes were compared with control 
responses to the first ATP addition (Fig. 26). Portal vein pressure 
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changes by prostaglandin F2a (2 uM), a vasoactive prostaglandin, were 
also observed after the second addition of ATP. Comparison of the 
control group with the indomethacin treated group at 1 min after ATP 
addition showed that the portal vein pressure induced by 20 uM ATP was 
18.7 + 0.46 and 15.6 + 0.25 mmHg, respectively (P<0.005) (Fig. 27). 
Prostaglandin F2a also increased portal vein pressure (Fig. 27). 
Indomethacin also inhibited ATP-induced glucose production in the 
perfused liver. Indomethacin, however, by itself did not affect glucose 
production rate. Glucose production rate by 40 uM ATP was significantly 
reduced (P<0.05) from a control value of 125.4 + 6.9 to 84.6 + 11.6 
moles/gm/hr in 50 uM indomethacin treated liver (Fig. 28). 
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FIGURE 26 
RECORDING OF CHANGES IN PORTAL VEIN PRESSURE BY 
ATP AND INDOMETHACIN 
The liver was perfused with a constant flow of 62 ml/min. ATP 
was added into the perfusate at 30 minutes of perfusion and then at 40 
indomethacin was added. 10 or 15 minutes after indomethacin, same 
amount of ATP was added. 
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FIGURE 27 
EFFECTS OF INDOMETHACIN ON PORTAL VEIN PRESSURE 
INDUCED BY ATP 
Each point represents mean+ S.E.M. for 7 livers. 
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FIGURE 28 
EFFECTS OF INDOMETHACIN ON ATP-INDUCED 
GLUCOSE PRODUCTION 
Livers were perfused under a constant perfusion pressure of 28 
.. 
Means + S .E .M. of glucose production rate are depicted. 
* 
denotes P<0.001 compared to control and ** denotes P<0.05 compared to 
ATP addition. 
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CHAPTER V 
DISCUSSION 
The major findings of this dissertation research deal with the 
effects of exogenous ATP on hepatic oxygen consumption, K+ movements, 
glucose production, and hemodynamics. Each of the above effects will 
now be discussed in reference to underlying mechanisms of ATP action. 
However, since these effects were obtained in the context of the use of 
exogenous ATP 
characteristics 
addressed. 
in the isolated perfused rat liver, 
of the liver perfusion model and ATP will 
A. Isolated Liver Perfusion Model 
the key 
first be 
There are several experimental models for the study of hepatic 
circulation and metabolism--including in vitro studies, isolated 
perfusion techniques, slice techniques, isolated hepatocytes and 
isolated subcellular preparations. The isolated perfused liver 
preparation has many advantages: it preserves intact cells; it provides 
an environment similar to in vivo; the chemical composition, substrate 
and hormone concentration and temperature can be easily controlled; and 
it eliminates complicated interactions with other organs via neural and 
humoral effects (116). Liver perfusion as an analytical physiological 
method has a history of over one hundred years. In early studies, 
mainly large animal livers such as dog or cat were used for 
perfusions. The perfusion model of the isolated rat liver originated 
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from Trowell (333). Subsequently Miller and his associates (24R) 
developed an extra-corporeal apparatus and an operative procedure for 
the perfusion of the isolated rat liver which has been used by many 
investigators up to the present. The rat liver has several advantages 
for perfusion. One, it requires less operative time (about 10 minutes 
from anesthesia to total removal of the liver) than larger animals such 
as rabbits, dogs or pigs; two, the rat liver is less susceptible to 
vasoactive factors than that of the dog and rabbit; and three, it 
requires small amounts of perfusion medium (249). There are two types 
of isolated liver perfusion--recirculating and non-recirculating 
systems. The non-recirculating system has several advantages; one, it 
maintains constant substrate or drug concentration of the perfusate and 
two, there is no accumulation of products during the perfusion period. 
On the other hand, a recirculating ~ystem has the advantage that it is 
possible to determine small changes in metabolites (for example, glucose 
and lactate production or ion movements), and it requires small amounts 
of perfusion medium. 
present study. 
A recirculating system was employed for the 
Most rat liver perfusions are performed with either a red blood 
cell free-medium or with a semisynthetic medium (physiological buffer 
plus washed red blood cells). Red blood cells (from many species 
including the human, cow, dog, pig, sheep and rat) increase oxygen 
carrying capacity and permit perfusion flow rates sufficiently low as to 
maintain adequate oxygenation. Miller et al. (248) perfused livers at 
flow rates of 1.0 - 3.0 ml/gm/min for their definitive study of hepatic 
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protein synthesis. Schimassek ( 295) employed 1 ml/ gm/min of perfusion 
flow for study of mitochondrial respiration. For the study of 
gluconeogenesis livers were perfused at a flow rate of 6.R - 7.2 ml/min 
in 90 to 140 gm rats--approximately 1.3 ml/gm/min (119). In most 
studies of rat liver perfusion with buffer enriched with erythrocytes, a 
low perfusion flow was employed. Exceptionally, Brauer et al. ( 41) 
perfused rat livers at an extremely high perfusion flow of 93 ml/min 
(approximately 8.4 ml/gm of liver/min) in their study of bile 
secretion. A significant problem with the red blood cell medium is that 
erythrocytes consume glucose and produce lactate and also may affect ion 
movement (151). Therefore, in the present study which had an interest 
in the effects of ATP on glucose production, lactate production and K+ 
movement, the red blood cells were omitted from the perfusion medium. 
Since red blood cell free-medium (for instance, KRB) has a low 
oxygen-carrying capacity, a high perfusion flow is required to achieve 
adequate oxygenation. Friedman and Rasmussen (140) perfused rat livers 
with erythrocyte free-medium at a flow rate of 24 ml/min in 100 gm rat 
(5.4 ml/gm/min) in studies of gluconeogenesis. Glycogenolysis by 
glucagon and metabolic inhibitors was studied under KRB perfusion at a 
flow rate of 30 ml/min (3.3 ml/gm/min, 197) and Debeer et al. (101) 
perfused livers with Krebs-Henseleit bicarbonate buffer at flow rates of 
7-8 ml/gm/min. Eisenstein et al. (113) perfused adrenalectomized rat 
livers with KRB at flow rates of 10-12 ml/gm/min in a study of adrenal 
cortical influences on carbohydrate metabolism. 
As described above, perfusion flow rates with erythrocyte free-
122 
medium are commonly much higher than those with erythrocyte containing 
medium. At a high perfusion flow the endothelial cell may be injured; 
on the contrary, at a low perfusion flow tissue may fall into hypoxic 
states ( 297). Therefore, it is important to maintain an adequate 
perfusion flow to prevent cell injury or hypoxia. Sugano et al. (323) 
reported that when rat livers were perfused with oxygenated erythrocyte 
free-medium at flow rates between 3-3.5 ml/gm/min, the rates of glucose, 
pyruvate and lactate production, the rate of oxygen consumption, and the 
tissue contents of adenine nucleotides were similar to those observed 
with perfusion system containing erythrocytes. However, in that study 
they maintained the perfused liver at 32°C to reduced oxygen demand. If 
they carried out their experiment at normal temperature (for instance at 
37°C), a higher perfusion flow might have been required. 
In the present study rat livers were perfused with KRB at flow 
rates of 60 to 64 ml/min (5.1 ml/gm liver/min) at 36°C. This flow rate 
is higher than that used by Kimura et al. (214, 3.1 ml/gm/min) and Jakob 
and Diem (197, 3.3 ml/gm/min) but less than that used by Brauer et al. 
(41, 8.4 ml/gm/min), Eisenstein et al. (113, 10-12 ml/gm/min), Bloxam 
(37, 9.9 ml/gm/min) and almost the same as that used by Friedman and 
Rasmussen (140, 5 .3 ml/ gm/min). One reason this perfusion flow was 
chosen was that oxygen consumption showed saturation phenomenon at this 
range in the relationship between oxygen consumption and perfusion flow 
(Fig. 11). 
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B. Characteristics of ATP 
Adenosine triphosphate (ATP) is the universal free energy source in 
biological systems. It is formed mainly via oxidative-phosphorylation 
in the inner compartment of mitochondria. ATP contains two high energy 
bonds. Free energy is liberated when ATP is hydrolyzed to adenosine 
diphosphate (ADP) and orthophosphate (Pi) or when ATP is hydrolyzed to 
adenosine monophosphate (AMP) and pyrophosphate (PPi). Thus ATP provides 
free energy for the performance of mechanical work in muscle 
contraction, active transport of molecules and ions across the membrane, 
and the synthesis of cellular components such as protein, lipid and 
carbohydrate. 
The ATP formed in the mitochondria is transported across the 
mitochondrial membrane into the cytosol by an ATP-ADP carrier (341). 
The intracellular concentration of ATP varies among different cell 
types--namely, 4-5 mM in muscle cells (160, 262), 1.8-4.5 mM in liver 
cells (197, 208, 334, 337), 1.3 mM in fibroblasts, 2.2 mM in PCM3 hybrid 
cells and 0.6 mM in P-388 lymphoma cells (13). In addition 
intracellular ATP concentration is decreased under various cell 
conditions--in hepatic ischemia (180, 266), by burns (352), after 
administration of endotoxin, in hypoxia and in hemorrhagic shock (2nQ). 
In contrast to high intracellular concentrations, only 1 uM of 
ATP is found in the human plasma (135). There is, however, an arterio-
venous difference of plasma ATP concentration during sustained exercise 
(137). The existance of extracellular ATP indicates that ATP can be 
released out of cells. The sources of plasma ATP were reported as 
active skeletal muscle (134, 136), erythrocytes (20, l'.B), blood 
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platelets (137), vascular endothelial cells (276), and nervous cells 
(182). In addition, the release of ATP from purinergic nerve endings as 
a neurotransmitter or co-transmitter has been well-recognized (52, 55, 
58, 320). 
As described above, the major function of intracellular ATP is as 
a free energy source for most active process in the body. In addition, 
extracellular ATP may have important physiological functions including 
changes in vascular resistance, regulation of tissue metabolism and as a 
neurotransmitter. 
C. Mechanisms .£!.ATP Action .£!!_ Oxygen Consumption 
The liver is a unique organ which has two afferent blood 
supplies--hepatic arterial and portal venous, both of which participate 
in the supply of oxygen. In the fasting state, about 50% of hepatic 
oxygen is supplied by the portal vein and 50% by the he pa tic artery 
(65). Many authors have reported an oxygen consumption rate in the 
perfused rat liver between 50 and 70 ml/gm liver/min (17, 101, 151, 232, 
295, 298). Although values as low as 16.7 (331) 26.7 (159) and 36.7 
ml/gm/min (323) have been reported, these results might be due to low 
temperature (32°C) or extremely low perfusion flow (0.2 ml/gm/min). The 
oxygen consumption rate of 53 ml/gm/min in the basal state in present 
study is therefore consistant with other published studies. 
The oxygen extraction or consumption by the liver is dependent 
upon the conditions of perfusion flow, substrate level, hormone 
concentration and various drugs. At low oxygen supply or low perfusion 
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flow, the oxygen extraction rate increased (17, 233). Exogenous 
substrates for gluconeogenesis also increased oxygen consumption ( 101, 
322). Catecholamines or glucagon also increased oxygen consumption (83, 
322). In the current study ATP decreased not only perfusion flow but 
also oxygen extraction in early phase after ATP (40 and 160 uM) 
addition; consequently it decreased oxygen consumption at these 
concentrations. Among possible mechanisms for the decrease in hepatic 
oxygen extraction due to ATP is that ATP may decrease oxygen consumption 
of the hepatocyte directly. According to Maxild (239), externally added 
ATP (0.1 - 10 mM) caused an elevation of ATP content in renal cortical 
tissue accompanied by a reduction of renal glucose utilization and 
oxygen consumption. This effect may be due to allosteric inhibition of 
glycolytic enzymes by ATP. Another mechanism of ATP action on oxygen 
use may involve redistribution of perfusion flow within the liver. The 
liver has heterogeneity in glycogen content (100), mitochondrial number 
and size (231, 343) and enzyme distribution (304) in different hepatic 
zones. The peripheral hepatocytes ( periportal cell) contains fewer 
mitochondria than central hepatocytes; however peripheral cells have 
larger total mitochondrial volumes, membrane area of cristae, and larger 
matrix per cell (231). Therefore, the peripheral region is associated 
with high oxygen consumption. Daniel and Prichard (95, 96) demonstrated 
uneven distribution of perfusion flow by certain stimuli using serial 
angiography. Stimulation of the hepatic nerves or administration of 
adrenaline shifted the portal perfusion flow through central, deeper 
parts due to constriction of small portal vessels. Daniel and Prichard 
(95) also observed that when the intrahepatic blood flow is shifted in 
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this manner, the portal blood reached the inferior vena cava more 
rapidly than when the liver is perfused throughout. If ATP constricted 
small branches of the portal vein, the perfusate would flow readily 
through the central zone. The perfusion flow passing through this area 
would have less chance for contact with parenchymal cells. Conversely, 
if ATP led to much more flow through the less oxygen-consuming region 
(central zone), then the perfusate would retain a high oxygen content. 
Although anatomical intrahepatic shunts (portal-hepatic venous shunts) 
have not been proved in the rat liver (96), the shift of hepatic portal 
perfusion flow by ATP may serve as a kind of physiological shunt. 
During the period of ATP action, the hepatocytes in the less-perfused 
region (peripheral zone) might undergo a oxygen-debt which caused 
compensated reactive oxygen uptake in the late phase; that is the 
oxygen-debt was paid back by a greater extraction. A similar reactive 
oxygen uptake was reported in the cat liver following partial occlusion 
of the hepatic artery (233). In addition, since ATP increased hepatic 
lactate production (Fig. 6), it is possible that the oxygen consumption 
might be increased as the lactate was used for gluconeogenesis as a 
substrate by the liver. 
However, at low concentration of ATP ( 10 uM), there was no 
biphasic phenomenon of oxygen extraction. ATP only increased oxygen 
extraction. Two possibilities can be considered for the latter 
effect. First, at low concentrations ATP has a characteristics of 
increasing oxygen consumption by unknown mechanisms. Second, a 
reduction perfusion flow by ATP in certain region may increase oxygen 
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extraction because low perfusion flow or low oxygen supply increases 
oxygen extraction rate by a compensation mechanism (17, 323). Although 
we did not measure any acute low oxygen extraction in the early phase 
after ATP addition, it might be masked by following reactive oxygen 
extraction. Even though perfusion was decreased, oxygen consumption 
rate was increased by 10 uM of ATP. This may indicate that the reactive 
greater oxygen extraction overcame the reduction of flow itself. 
D. Mechanism of ATP Action on K+ Movements 
D'Silva (109) first observed that the transient elevation of 
plasma K+ which follows the intravenous administration of adrenaline is 
a consequence of the hepatic release of K+. Many other drugs and 
procedures also elevate plasma the K+ release is promoted by 
cr-adrenoceptor agonists (46, 169, 171, 294), glucagon (198), cyclic AMP 
(316), ionophore 23187 (46, 287), hemorrhage (109), hypoxia (273) and 
carbon dioxide inhalation (123). 
The present study indicated that ATP also increases K+ release 
from the isolated perfused rat liver. Similar effects were observed in 
the isolated hepatocytes from guinea-pigs (46). The mechanism( s) by 
which ATP causes K+ efflux in the liver is not well understood. 
However, the following evidence suggests that calcium is involved in K+ 
movements. An elevation in intracellular ca++ as induced by 
intracellular ca++ injection, cation ionophore or a-receptor agonists 
specifically increased the passive K+ permeability (PK) of the plasma 
membrane in various tissues--rat and human erythrocytes (9, 287, 142), 
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cat aspersa neurons (244, 245), barnacle photoreceptor (161), rat 
parotid and sublingual glands (280, 281, 282), taenia coli (45) and 
liver cells (46, 169, 294, 316). Although there is no direct evidence 
that ATP increases intracellular Ca++ level in the liver cell, exogenous 
ATP increases ca++ uptake by rat mast cells (91, 92), Ehrlich ascites-
tumor cells (223), chicken intestinal epithelial cells (213) and 
erythroleukemia cells ( 69). Thus ATP may increase intracellular ca++ 
levels in the hepatocyte and consequently increase K+ efflux just as 
elevations in intracellular ca++ by catecholamine affects K+ efflux in 
other tissues. It is of interest that catecholamines and the adenine 
nucleotides--ATP, ADP and cyclic AMP--hyperpolarize liver cells ( 170, 
200, 316). This is further evidence of ca++-dependent, K+-conductance 
change by ATP in the hepatocytes. However, it is not clear how 
intracellular Ca++ alters K+ permeability in the plasma membrane. 
Another possibility for the K+ efflux is that ATP alters the Na-
K+ transport system in the plasma membrane. In rat liver intracellular 
Na+ and Cl- concentrations are low, and intracellular K+ concentration 
is high with respect to extracellular fluid. The maintenance of the 
intracellular cation concentration is dependent upon transport 
mechanisms which are linked to metabolic activity of the cells (111, 
312). Therefore, when the metabolism of liver cell is depressed by low 
temperature or by metabolic inhibitors such as cyanide and 2,4-
dinitrophenol, the liver cell loses K+ and gains Na+ (115, 172, 173, 
224, 335, 336). Anoxia also caused release of K+ in the perfused rat 
liver (273). In the present study, ATP decreased perfusion flow (Fig. 
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15) and decreased oxygen consumption (Fig. 13). If ATP produced an 
extreme decrease in perfusion flow in certain local regions--
particularly in the peripheral zones--oxygen delivery into this area and 
ATP availability in the liver cell should be low. The limitation of ATP 
in the liver could inhibit the Na+-K+ pump activity and then cause K+ 
efflux to occur. 
E. Glucose Production ~ATP 
The liver is an especially key organ in glucose regulation. 
Blood glucose levels, critical for life, are maintained by 
glycogenolysis in the fed state and by hepatic gluconeogenesis in the 
fasted state. Glycogenolysis and gluconeogenesis are determined by many 
factors--hormones, hepatic blood flow, oxygen supply and intracellular 
substrate levels as well as ATP, AMP and glucose-6-phosphate. In 
addition extracellular ATP also affects glucose metabolism. Levine 
(228) demonstrated that intravenous administration of ATP caused 
hyperglycemia in the rat. In the present study exogenous ATP increased 
glucose output in the perfused fed rat liver (Fig. 4). Clemens et al. 
(84) observed a similar result. 
Two possible mechanisms for glucose production by ATP will now be 
discussed. First, vasoconstriction of the portal vein by ATP may 
indirectly produce glucose and lactate release. Since ATP decreases 
portal vein perfusion flow, and oxygen extraction by the liver (Fig. 13, 
15), it may lead to a regional hypoxic condition. Since hepatic 
glycogenolysis is very sensitive to the oxygen tension in the liver, 
130 
glucose efflux occurs. As oxygen delivery to the liver is further 
reduced, glycogenolysis is also accelerated (62, 174, 197, 351). 
Hepatic glycogenolysis is catalyzed by glycogen phosphorylase which 
exists in two forms--phosphorylase a and b. In normal states, 
phosphorylase exists mainly as phosphorylase b (261) which is the 
dephosphorylated form. Phosphorylase b is subjected to allosteric 
regulators. For example, phosphorylase b is inhibited by ATP or 
glucose-6-phosphate and it is activated by AMP. Therefore, in the 
normal state, glycogenolysis is inhibited by high levels of 
intracellular ATP or glucose-6-phosphate and by low concentration of 5'-
AMP. However, in hypoxic conditions, tissue ATP levels decline and AMP 
and Pi accumulate rapidly (122, 174, 344). Therefore, phosphorylase may 
be activated by low ATP levels (via deinhibition) and by high AMP levels 
in the liver cell. Lactate production is also one of the responses to 
hypoxic condition in the liver (16, 17, 174, 301, 351). In the present 
study, ATP increased lactate production in the perfused liver (Fig. 
6). This may also be due to hypoxic stimuli by decreasing oxygen 
delivery to the liver by the same mechanism as described above. 
To eliminate the hypoxic effect by low perfusion flow, the effect 
of ATP on glycogenolysis was observed under constant perfusion flow. 
Although glucose production rate with constant perfusion flow was lower 
than with constant perfusion pressure, ATP still increased glucose 
output (Fig. 5). This indicates that low perfusion flow and 
consequently local hypoxia is not the sole mechanism for glycogenolysis 
by ATP. 
131 
The question arises whether ATP has direct effects on 
glycogenolysis in the hepatic parenchymal cell. In the present study 
using isolated hepatocytes, ATP actually decreased glucose production 
rather than increased it (Fig. 8). However, Clemens et al (85) reported 
different results; in their study 10-4M of ATP increased glucose output 
23% in the isolated hepatocyte. Although they used ATP-MgC12 instead of 
ATP-Na as in present study, this may not be the critical cause of 
discrepancy between two results. To interpret the inhibitory effect of 
ATP on glucose production in the isolated hepatocyte, ATP-entering the 
cell and its intracellular role will now be considered. Generally, it 
is assumed that ATP does not cross the plasma membrane (150). However, 
there are many direct and indirect evidences that ATP does cross the 
plasma membrane in some tissues including kidney (239), skeletal muscle 
(74, 76), lymphomas cells (13), nervous cell (270) and liver (80, 152, 
181). As described above, intracellular ATP can control the rate of 
glycogenolysis by its action on phosphorylase .£_without interconversion 
of enzyme forms. Low glucose output by ATP may be due to inhibition of 
phosphorylase via allosteric effects. However, it is uncertain whether 
200 micromolar concentration of exogenous ATP can change the millimolar 
range of intracellular ATP enough to suppress the phosphorylase 
activity. But it may be possible that the entering ATP is accumulated 
in cell and thus breaks the steady state of intracellular ATP 
concentration. Thus entering ATP may act as a "priming" effector on the 
resynthesis of ATP (266). 
On the other hand, in the present study glucagon increased 
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glucose output in the isolated hepatocyte (Fig. 8). It has been well 
known that a variety of hormones including catecholamines and glucagon 
have a stimulatory effect on hepatic glycogenolysis which is mediated by 
cyclic AMP mechanism and a cascade of reactions (178, 183, 186, 197, 
263). Therefore, the stimulatory effect of glucagon on glycogenolysis 
in the present study agree with numerous investigations. ATP inhibited 
glucagon-stimulated glucose output (Fig. 8). Under hormone stimulation, 
phosphorylase .E_ converts to phosphorylase .!. which is not subjected to 
any allosteric regulators even under high levels of ATP or glucose-6-
phosphate. Thus the mechanism of the ATP action on glucagon-stirnulated 
glucose output in the hepatocyte is not clear. 
Phosphofructokinase (PFK) is one of the regulatory enzymes of 
glycolysis in the liver and its activity is suppressed by high levels of 
intracellular allosteric inhibitors including ATP, creatine phosphate 
and low levels of activators such as AMP, ADP and fructose-1,6-
diphosphate (145, 225). Glucagon also inhibits PFK and pyruvate kinase 
of the liver cell (82, 202). In the present study ATP and glucagon 
significantly inhibited lactate production in the he pa tocyte (Fig. 10) 
and similar results were reported by other investigators (152, 218, 219) 
in the normal and shocked hepatocytes. The effects of ATP and glucagon 
on lactate production may be due to inhibition of PFK by allosteric 
modulation. 
A second mechanism of ATP action on glucose production may be 
related to alteration in prostaglandins in the perfused liver 
preparation. Prostaglandins or prostaglandin-like substance (PLS) are 
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released from many tissues by various stimuli. One of the stimuli for 
prostaglandin release is adenine nucleotide levels. ATP and adenosine 
diphosphate (ADP) acts as potent releasers of prostaglandins from a wide 
variety of isolated perfused organs including liver, kidney, spleen, fat 
pad, heart and lung (252, 260). There are many kind of prostaglandins 
(PG) in biological systems for example, the PGE-series, PGF-series, PGA-
series and PGB-series. Each tissue releases different kinds of 
prostaglandins and the response to each prostaglandin depends on the 
respective tissues. Glycogen breakdown by PGE, was demonstrated in the 
isolated perfused rat liver (227, 347) and in the rat liver slice 
(38). This finding implicates that glycogenolysis by PGE, is related to 
PG receptors and adenylate cyclase activation in the liver plasma 
membrane. Purified prostaglandin E1 receptors are isolated from rat 
liver plasma membrane (288, 289, 314, 315). Although some controversy 
exists (229), many investigators have demonstrated that prostaglandin F. 1 
stimulated adenylate cyclase and consequently increased cyclic AMP 
content in the hepatocyte (267, 288, 289, 325, 347, 353). In addition, 
indomethacin, an inhibitor of prostaglandin synthesis, depressed 
glucagon- or epinephrine-stimulated hepatic glucose output in vivo (146, 
250). In the present study indomethacin attenuated the ATP-induced 
glucose production (Fig. 28). Therefore, glucose production by ATP in 
the perfused liver may be mediated by prostaglandin E1• In summary, 1) 
ATP may release prostaglandin E1 from liver cells including vascular 
endotheliwn, Kupffer cells and vascular smooth muscle cells, 2) PGE 1 
may increase adenylate cyclase in the plasma membrane and increase c-AMP 
level in the hepatocyte and 3) c-AMP may increase phosphorylase 
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activity and finally lead to glycogenolysis. 
F. Role ~ ATP in Hepa tic Hemodynamics 
ATP, ADP, AMP and adenosine are potent vasodilators in most 
vascular beds including skeletal muscle (110, 132, 216), skin (132), ear 
(23), intestinal (90, 132, 161) and coronary system (23, 28, 97, 107, 
349). However, vasoconstrictor responses to ATP occur in various tissue 
preparations. ATP increased the basal tension of dog's saphenous strip 
(338), aortic strip (143) and human umbilical artery strip (127). 
Contractile responses to ATP were also demonstrated in other smooth 
muscle such as rat uterine (94), guinea-pig taenia coli (87, 236), 
guinea-pig vas deferens ( 207), urinary bladder (42, 58) and stomach 
(44). ATP increased renal vascular resistance in the isolated perfused 
rat kidney (185, 339) and adenosine caused vasoconstriction in the 
perfused rat liver (193). Thus the hemodynamic response to ATP depends 
upon the tissue under study. 
In the present study, effects of ATP on hepatic hemodynamics were 
studied in the isolated perfused rat liver. ATP decreased portal vein 
perfusion flow under constant perfusion pressure (Fig. 15). Al though 
the vasoconstrictor effect of adenosine has been already reported in the 
perfused rat liver (193), vasoconstrictor response to ATP in the 
perfused liver have received little attention. The vasoconstrictor 
effects of ATP were also proved under constant perfusion flow by 
demonstration of portal vein pressure development. The increase in 
vascular resistance occurred rapidly and continued for several minutes 
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and then returned to normal. This decrease may be due to decay of ATP 
after initiation of vasoconstriction. There are three ectoenzymes for 
metabolism of external adenine nucleotides--nucleoside triphosphatase, 
nucleoside diphosphatase, and 5'-nucleotidase (274). These 
ectonucleotidase system are found in various tissue including red blood 
cell (272), vascular endothelial cell (88, 230, 274, 275), fibroblasts 
(102, 104), and plasma (138, 188, 251). In the perfused liver the 
ectoenzyme of the vascular endothelial cell and smooth muscle cell may 
degrade ATP. The ectonucleotidase system degrades ATP to ADP, then to 
AMP and finally to adenosine (275). 
Since hepatic vessels have a rich innervation, the hepatic nerves 
may have significant effects on the hepatic circulation (158). Hormones 
and some vasoactive drugs including catecholamines, histamine, 
serotonin, dopamine, angiotensin and vasopressin also affect the hepatic 
circulation (6, 7, 19, 158, 303). However, the exact sites of action of 
the hepatic vasopressors are not known. Two major sphincteric sites 
have been found in the hepatic circulation--inlet sphincters at the 
presinusoidal region and outlet sphincters at the postsinusoidal region 
(36, 168, 189, 241). Hepatic arterioles, portal venules and hepatic 
venules also contribute to the regulation of hepatic circulation 
(156). Therefore, the hepatic inflow and outflow are determined by net 
effects between presinusoidal and postsinusoidal resistance change. To 
clarify the site of ATP action, liver weight changes were studied. ATP 
decreased liver capacitance (Fig. 21). This result suggests that 
either 1) ATP increases resistance only in presinusoidal region or 2) 
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ATP increases vascular resistance both in presinusoidal regions and 
postsinusoidal regions but the effect of ATP in the presinusoidal region 
exceeds that in post sinusoidal. However, it does not mean that the 
original response of presinusoidal region to ATP is greater than 
post sinusoidal. Because most of ATP might be degraded during passing 
through sinusoids, the concentration reaching the postsinusoidal region 
might be very low. 
Not only ATP but also other adenine nucleotides--ADP, AMP, and 
adenosine--increased portal vein resistance in the perfused liver (Fig. 
23). Although their potency was lower than that of ATP, ADP, AMP and 
adenosine also increased glucose output. This similar character 
indicates that purine compounds (ATP, ADP, AMP and adenosine) may be 
possessed of similar action site in the perfused liver. Burnstock (51) 
has proposed the existance of two purinergic receptors on vascular 
smooth muscle: the P1 purino-receptors are most sensitive to adenosine 
and P2 purino-receptors are most sensitive to ATP. According to his 
hypothesis the vasodilation effect of purine compounds on vascular beds 
of skeletal muscle or the coronary system is mediated by purino-receptor 
mechanism. However, the exact mechanism for vasodilation after 
activation of such receptor is not clear. 
The question still remains as to how ATP increases hepatic 
vascular resistance. Prostaglandins may also be involved in ATP-induced 
vasoconstriction of hepatic vessels. It is clear that prostaglandins 
are released from most animal tissues into the circulation spontaneously 
and following drug, nerve and hormonal stimulation (28~). As referred 
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to previously, ATP and ADP are potent stimulators of prostaglandin 
release from various isolated perfused organ including liver, kidney, 
spleen, heart and lung (252, 260). Endothelial cell, vascular smooth 
muscle cell, fibroblast and Kupffer cell have been recognized as 
prostaglandin releasing cells (1, 2, 15, 264, 341). With respect to 
prostaglandin responses, a single prostaglandin compound can exert 
opposite actions in different tissue preparations. For example PGI 2 
increased blood flow through kidney, adrenal gland, small intestine, 
brain and pituitary gland; whereas pancreatic and skeletal muscle 
perfusion were diminished by PGI2 (299). PGE 1 decreased the resistance 
in the coronary vessel, femoral vein, and renal artery; whereas PGE 1 
caused a biphasic change in the portal venous pressure, an initial 
increase followed by a decrease (255, 257), and it also caused 
contraction in several isolated smooth muscle preparation (191, 253). 
However, generally, prostaglandins of the F-series increase vascular 
resistance and increase contractility of isolated smooth muscle 
including aortic strip, stomach muscle, collateral arteries, colon and 
bladder (3, 5, 190, 253, 345). Smooth muscle contraction by 
prostaglandins is accomplished by ca++ ion mobilization from calcium 
storages. increase ca++ influx from 
extracellular fluid and increases intracellular release of Ca* from 
sarcoplasmic reticulum, mitochondria or plasma membrane itself (5, 66, 
67, 153, 154). In a preliminary study the vasoconstrictor effect of ATP 
could not be demonstrated in ca*-free perfusion medium. This may 
indicate that ca++ influx from extracellular fluid is important to the 
ATP-prostaglandin-vasoconstriction axis. 
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Needleman et al (260) did not identify the prostaglandins which 
are released 
prostaglandins 
from the perfused liver by ATP 
measured in the present 
stimulation, nor · were 
study. However, if 
prostaglandins are released from the perfused liver, as previous reports 
indicate for PGE and PGF2a , then vasoconstriction by PGF2a in the 
present study can be an interpretation of ATP' s effects on hepatic 
resistance change. One point of the evidence for the involvement of 
prostaglandins in ATP-induced vasoconstriction in the perfused liver is 
that indomethacin, a prostaglandin synthesis inhibitor, attenuated the 
ATP-induced portal vein pressure (Fig. 27). Several investigators also 
reported that indomethacin depressed ATP-induced contraction in guinea-
pig digestive tract (205), guinea-pig myometrium (106), rabbit detrusor 
(99, 105), guinea-pig taenia coli (57) and human umbilical artery 
(127). This suggests that the vasoconstrictor effect of ATP in the 
perfused liver is mediated by prostaglandin(s). 
Fig. 29 represents a summary of possible mechanisms of ATP action 
on hepatic hemodynamics and glucoregulation in the perfused rat liver. 
ATP may release prostaglandin( s) from liver cells such as endothelial 
cells, vascular smooth muscle cells, and Kupffer cells. Two lines of 
prostaglandin action--glucoregulation and hemodynamics--are 
considered. First, prostaglandin(s) act on parenchymal cells and lead 
to increase in adenylate cyclase activity, increase in phosphorylase 
activity, and finally increase in glucose and lactate production. 
Second, prostaglandin may act on vascular smooth muscle cells and lead 
to an increase in Ca++ availability in the cell, cause smooth muscle 
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contraction, and finally increase resistance of the hepatic vessel. The 
resultant low perfusion flow may decrease oxygen delivery into the ·1iver 
which then stimulates glycogenolysis. 
SUMMARY AND CONCLUSIONS 
The present study was designed to investigate the action of ATP 
on liver carbohydrate metabolism and on hepatic hemodynamics. Two 
experimental models~the isolated perfused rat liver preparation and the 
isolated rat hepatocyte preparation--were employed. In the first series 
of experiments several metabolic changes including glucose production, 
lactate production, oxygen consumption and K+ ion movement were 
measured. In the second series of experiments the effects of ATP on 
hepatic circulatory resistance, changes in portal vein perfusion flow, 
portal vein perfusion pressure, hepatic arterial perfusion pressure and 
hepatic capacitance were measured. 
The main results of the experiments were: 
1. ATP increased glucose production in the isolated perfused rat liver 
under either constant perfusion pressure or constant perfusion 
flow. Lactate production was also increased by ATP with constant 
perfusion pressure. 
2. ATP did not increase glucose production in the isolated 
hepatocytes. However, it inhibited glucagon-stimulated glucose 
output. ATP also inhibited lactate production in the isolated 
hepatocytes. 
3. ATP increased oxygen consumption at low concentration (10 uM) and 
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inhibited it at high concentration (40 and 160 uM) in the perfused 
liver. 
4. ATP increased K+ efflux in the isolated perfused liver. 
5. Indomethacin attenuated ATP-induced glucose production in the 
isolated perfused liver. 
6. ATP decreased perfusion flow and increased portal vein perfusion 
pressure. ATP also increased hepatic arterial perfusion pressure. 
7. ATP reduced hepatic capacitance by increasing the resistance of the 
presinusoidal region in the liver. 
8. The adenine derivatives including adenosine, AMP, ADP and ATP also 
decreased perfusion flow and increased glucose output. ADP 
decreased oxygen consumption, however, adenosine and AMP did not. 
The order of activity of the adenine compounds were ATP, ADP, AMP = 
adenosine. 
9. Prostaglandin F 2a increased portal vein pressure. Indomethacin 
attenuated ATP-induced portal vein pressure. 
In conclusion, the increments of glucose production and hepatic 
circulatory resistance with ATP in the isolated perfused rat liver may 
be mediated by prostaglandins which are released from hepatic cells by 
exogenous ATP stimulation. 
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